BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O’Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331:1173-1180. [PMID: 7935654 DOI: 10.1056/nejm199411033311801] [Cited by in Crossref: 2467] [Cited by in F6Publishing: 441] [Article Influence: 88.1] [Reference Citation Analysis]
Number Citing Articles
1 Glenn Fowler M, Boivin MJ, Familiar I, Nyangoma B. Central Nervous System and Neurodevelopmental Outcomes of HIV+ and HIV exposed children: A Mini Review of Recent Findings and Lessons Learned from the Field. Neurosci Lett 2022;:136501. [PMID: 35122932 DOI: 10.1016/j.neulet.2022.136501] [Reference Citation Analysis]
2 Best BM, Capparelli EV. Implications of gender and pregnancy for antiretroviral drug dosing. Curr Opin HIV AIDS. 2008;3:277-282. [PMID: 19372979 DOI: 10.1097/coh.0b013e3282f39f7e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lambert JS, Nogueira SA, Abreu T, Machado ES, Costa TP, Bondarovsky M, Andrade M, Halpern M, Barbosa R, Perez M. A pilot study to evaluate the safety and feasibility of the administration of AZT/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil. Sex Transm Infect 2003;79:448-52. [PMID: 14663118 DOI: 10.1136/sti.79.6.448] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
4 Goetghebuer T, Haelterman E, Marvillet I, Barlow P, Hainaut M, Salameh A, Ciardelli R, Gerard M, Levy J. Vertical transmission of HIV in Belgium: a 1986-2002 retrospective analysis. Eur J Pediatr 2009;168:79-85. [PMID: 18392638 DOI: 10.1007/s00431-008-0717-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
5 Premkumar A, Cassimatis I, Berhie SH, Jao J, Cohn SE, Sutton SH, Condron B, Levesque J, Garcia PM, Miller ES, Yee LM. Home Birth in the Era of COVID-19: Counseling and Preparation for Pregnant Persons Living with HIV. Am J Perinatol 2020;37:1038-43. [PMID: 32498092 DOI: 10.1055/s-0040-1712513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Hodgins S, Tielsch J, Rankin K, Robinson A, Kearns A, Caglia J. A New Look at Care in Pregnancy: Simple, Effective Interventions for Neglected Populations. PLoS One 2016;11:e0160562. [PMID: 27537281 DOI: 10.1371/journal.pone.0160562] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
7 Parker RG, Perez-Brumer A, Garcia J, Gavigan K, Ramirez A, Milnor J, Terto V Jr. Prevention literacy: community-based advocacy for access and ownership of the HIV prevention toolkit. J Int AIDS Soc 2016;19:21092. [PMID: 27702430 DOI: 10.7448/IAS.19.1.21092] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
8 Ivanova A, Hoberman S. Higher order response adaptive urn designs for clinical trials with highly successful treatments. J R Stat Soc Ser C Appl Stat 2015;64:175-89. [PMID: 25641991 DOI: 10.1111/rssc.12066] [Reference Citation Analysis]
9 Mirochnick M, Capparelli E, Dankner W, Sperling RS, van Dyke R, Spector SA. Zidovudine pharmacokinetics in premature infants exposed to human immunodeficiency virus. Antimicrob Agents Chemother 1998;42:808-12. [PMID: 9559787 DOI: 10.1128/AAC.42.4.808] [Cited by in Crossref: 33] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
10 Johnson EL, Swieboda D, Olivier A, Enninga EAL, Chakraborty R. Robust innate immune responses at the placenta during early gestation may limit in utero HIV transmission. PLoS Pathog 2021;17:e1009860. [PMID: 34432853 DOI: 10.1371/journal.ppat.1009860] [Reference Citation Analysis]
11 De Groot AS, Leibel SR, Zierler S. A Standard of HIV Care for Incarcerated Women: Northeastern United States’ Experiences. Journal of Correctional Health Care 1998;5:139-77. [DOI: 10.1177/107834589800500204] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
12 Hernandez S, Moren C, Catalán-García M, Lopez M, Guitart-Mampel M, Coll O, Garcia L, Milisenda J, Justamante A, Gatell JM, Cardellach F, Gratacos E, Miro Ò, Garrabou G. Mitochondrial toxicity and caspase activation in HIV pregnant women. J Cell Mol Med 2017;21:26-34. [PMID: 27577111 DOI: 10.1111/jcmm.12935] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Goulder PJ, Lewin SR, Leitman EM. Paediatric HIV infection: the potential for cure. Nat Rev Immunol 2016;16:259-71. [PMID: 26972723 DOI: 10.1038/nri.2016.19] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 11.0] [Reference Citation Analysis]
14 Chi BH, Stringer JS, Moodley D. Antiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan Africa. Curr HIV/AIDS Rep 2013;10:124-33. [PMID: 23440538 DOI: 10.1007/s11904-013-0154-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
15 Buchanan AM, Cunningham CK. Advances and failures in preventing perinatal human immunodeficiency virus infection. Clin Microbiol Rev 2009;22:493-507. [PMID: 19597011 DOI: 10.1128/CMR.00054-08] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
16 Proudnikov D, Randesi M, Levran O, Crystal H, Dorn M, Ott J, Ho A, Kreek MJ. Association of polymorphisms of the mu opioid receptor gene with the severity of HIV infection and response to HIV treatment. J Infect Dis 2012;205:1745-56. [PMID: 22457278 DOI: 10.1093/infdis/jis264] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
17 Smith C, Weinberg A, Forster JE, Levin MJ, Davies J, Pappas J, Kinzie K, Barr E, Paul S, McFarland EJ. Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir. Infect Dis Obstet Gynecol 2016;2016:9848041. [PMID: 27127401 DOI: 10.1155/2016/9848041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
18 Delvecchio R, Higa LM, Pezzuto P, Valadão AL, Garcez PP, Monteiro FL, Loiola EC, Dias AA, Silva FJ, Aliota MT, Caine EA, Osorio JE, Bellio M, O'Connor DH, Rehen S, de Aguiar RS, Savarino A, Campanati L, Tanuri A. Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models. Viruses 2016;8:E322. [PMID: 27916837 DOI: 10.3390/v8120322] [Cited by in Crossref: 162] [Cited by in F6Publishing: 150] [Article Influence: 27.0] [Reference Citation Analysis]
19 Grimes RM, Srivastava G, Helfgott AW, Eriksen NL. A study to determine the incidence and prevalence of newly discovered human immunodeficiency virus infection during the prenatal care period. Infect Dis Obstet Gynecol 2000;8:172-5. [PMID: 10968601 DOI: 10.1155/S1064744900000235] [Reference Citation Analysis]
20 Mammas IN, Theodoridou M, Kramvis A, Thiagarajan P, Gardner S, Papaioannou G, Melidou A, Koutsaki M, Kostagianni G, Achtsidis V, Koutsaftiki C, Calachanis M, Zaravinos A, Greenough A, Spandidos DA. Paediatric Virology: A rapidly increasing educational challenge. Exp Ther Med 2017;13:364-77. [PMID: 28352303 DOI: 10.3892/etm.2016.3997] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
21 Carosi G, Nasta P, Fiore S, Matteelli A, Cauda R, Ferrazzi E, Tamburrini E, Savasi V, Bini T, Ravizza M, Bucceri A, Vichi F, Murri R, Mazzotta F, d'Arminio Monforte A; Italian Working Group for the Women with HIV Management Guidelines. Women facing HIV. Key question on women with HIV infection: Italian consensus workshop. Infection 2009;37:168-78. [PMID: 19308320 DOI: 10.1007/s15010-008-7361-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
22 Kourtis AP. Prevention of perinatal HIV transmission: current status and future developments in anti-retroviral therapy. Drugs 2002;62:2213-20. [PMID: 12381220 DOI: 10.2165/00003495-200262150-00004] [Reference Citation Analysis]
23 Ades AE, Sculpher MJ, Gibb DM, Gupta R, Ratcliffe J. Cost effectiveness analysis of antenatal HIV screening in United Kingdom. BMJ 1999;319:1230-4. [PMID: 10550083 DOI: 10.1136/bmj.319.7219.1230] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.1] [Reference Citation Analysis]
24 Scalfaro P, Chesaux JJ, Buchwalder PA, Biollaz J, Micheli JL. Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment. Intensive Care Med 1998;24:247-50. [PMID: 9565807 DOI: 10.1007/s001340050558] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
25 Rongkavilit C, Mitchell CD, Nachman S. Management of the infant born to an HIV-1 infected mother. Paediatr Drugs 1999;1:325-30. [PMID: 10935430 DOI: 10.2165/00128072-199901040-00008] [Reference Citation Analysis]
26 Baeten JM, Haberer JE, Liu AY, Sista N. Preexposure prophylaxis for HIV prevention: where have we been and where are we going? J Acquir Immune Defic Syndr 2013;63 Suppl 2:S122-9. [PMID: 23764623 DOI: 10.1097/QAI.0b013e3182986f69] [Cited by in Crossref: 101] [Cited by in F6Publishing: 80] [Article Influence: 11.2] [Reference Citation Analysis]
27 Bryant Borders AE, Eary RL, Olszewski Y, Statton A, Handler A, Cohen MH, Garcia PM. Ready or not--intrapartum prevention of perinatal HIV transmission in Illinois. Matern Child Health J 2007;11:485-93. [PMID: 17508276 DOI: 10.1007/s10995-007-0192-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
28 Beekmann SE, Henderson DK. Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers). Infect Dis Clin North Am 2014;28:601-13. [PMID: 25287589 DOI: 10.1016/j.idc.2014.08.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
29 Sant'anna ACC, Seidl EMF, Galinkin AL. Mulheres, soropositividade e escolhas reprodutivas. Estud psicol (Campinas) 2008;25:101-9. [DOI: 10.1590/s0103-166x2008000100010] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Beltrami EM, Williams IT, Shapiro CN, Chamberland ME. Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev 2000;13:385-407. [PMID: 10885983 DOI: 10.1128/CMR.13.3.385] [Cited by in Crossref: 86] [Cited by in F6Publishing: 81] [Article Influence: 3.9] [Reference Citation Analysis]
31 Ciaranello AL, Seage GR 3rd, Freedberg KA, Weinstein MC, Lockman S, Walensky RP. Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity. AIDS 2008;22:2359-69. [PMID: 18981776 DOI: 10.1097/QAD.0b013e3283189bd7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
32 Mellins CA, Nestadt D, Bhana A, Petersen I, Abrams EJ, Alicea S, Holst H, Myeza N, John S, Small L, McKay M. Adapting Evidence-Based Interventions to Meet the Needs of Adolescents Growing Up with HIV in South Africa: The VUKA Case Example. Glob Soc Welf 2014;1:97-110. [PMID: 25984440 DOI: 10.1007/s40609-014-0023-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
33 Wilson LS, Hensic L, Paoli CJ, Basu R, Christenson M, Moskowitz JT, Wara D. The effect of prophylaxis on pediatric HIV costs. AIDS Care 2012;24:108-18. [PMID: 21780991 DOI: 10.1080/09540121.2011.592818] [Reference Citation Analysis]
34 Delicio AM, Milanez H, Amaral E, Morais SS, Lajos GJ, e Silva JL, Cecatti JG. Mother-to-child transmission of human immunodeficiency virus in aten years period. Reprod Health 2011;8:35. [PMID: 22129112 DOI: 10.1186/1742-4755-8-35] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
35 Money DM. Antiviral and antiretroviral use in pregnancy. Obstet Gynecol Clin North Am 2003;30:731-49, vii. [PMID: 14719848 DOI: 10.1016/s0889-8545(03)00089-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
36 Rainwater-Lovett K, Uprety P, Persaud D. Advances and hope for perinatal HIV remission and cure in children and adolescents. Curr Opin Pediatr 2016;28:86-92. [PMID: 26709685 DOI: 10.1097/MOP.0000000000000304] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
37 Wilkinson D, Karim SS, Coovadia HM. Short course antiretroviral regimens to reduce maternal transmission of HIV. BMJ 1999;318:479-80. [PMID: 10024252 DOI: 10.1136/bmj.318.7182.479] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
38 Potty RS, Sinha A, Sethumadhavan R, Isac S, Washington R. Incidence, prevalence and associated factors of mother-to-child transmission of HIV, among children exposed to maternal HIV, in Belgaum district, Karnataka, India. BMC Public Health 2019;19:386. [PMID: 30954068 DOI: 10.1186/s12889-019-6707-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
39 Fear WR, Kesson AM, Naif H, Lynch GW, Cunningham AL. Differential tropism and chemokine receptor expression of human immunodeficiency virus type 1 in neonatal monocytes, monocyte-derived macrophages, and placental macrophages. J Virol 1998;72:1334-44. [PMID: 9445034 DOI: 10.1128/JVI.72.2.1334-1344.1998] [Cited by in Crossref: 64] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
40 Kumela K, Amenu D, Chelkeba L. Comparison of anti-retroviral therapy treatment strategies in prevention of mother-to-child transmission in a teaching hospital in Ethiopia. Pharm Pract (Granada) 2015;13:539. [PMID: 26131041 DOI: 10.18549/pharmpract.2015.02.539] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
41 Ejigu Y, Tadesse B. HIV testing during pregnancy for prevention of mother-to-child transmission of HIV in Ethiopia. PLoS One 2018;13:e0201886. [PMID: 30092104 DOI: 10.1371/journal.pone.0201886] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
42 Varghese GM, Abraham OC, Mathai D. Post-exposure prophylaxis for blood borne viral infections in healthcare workers. Postgrad Med J 2003;79:324-8. [PMID: 12840120 DOI: 10.1136/pmj.79.932.324] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
43 Miró JM. The human immunodeficiency virus infection 40 years later. Med Clin (Barc) 2021:S0025-7753(21)00628-X. [PMID: 34930600 DOI: 10.1016/j.medcli.2021.09.020] [Reference Citation Analysis]
44 Yudin MH, Shapiro HM, Loutfy MR. Access to infertility services in Canada for HIV-positive individuals and couples: a cross-sectional study. Reprod Health 2010;7:7. [PMID: 20462451 DOI: 10.1186/1742-4755-7-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
45 Spector SA. Mother-to-infant transmission of HIV-1: the placenta fights back. J Clin Invest 2001;107:267-9. [PMID: 11160148 DOI: 10.1172/JCI12094] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
46 Yi Y, Yuan Y. An optimal allocation for response-adaptive designs. Journal of Applied Statistics 2013;40:1996-2008. [DOI: 10.1080/02664763.2013.800846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Yalamanchi S, Dobs A, Greenblatt RM. Gonadal function and reproductive health in women with human immunodeficiency virus infection. Endocrinol Metab Clin North Am 2014;43:731-41. [PMID: 25169564 DOI: 10.1016/j.ecl.2014.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
48 Goldenberg MJ. Placebo orthodoxy and the double standard of care in multinational clinical research. Theor Med Bioeth 2015;36:7-23. [PMID: 25663050 DOI: 10.1007/s11017-015-9317-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
49 Bland R, Coovadia H, Coutsoudis A, Rollins N, Newell M. Cohort profile: mamanengane or the Africa centre vertical transmission study. Int J Epidemiol 2010;39:351-60. [PMID: 19336438 DOI: 10.1093/ije/dyp165] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
50 Janes H, Corey L, Ramjee G, Carpp LN, Lombard C, Cohen MS, Gilbert PB, Gray GE. Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa. AIDS Res Hum Retroviruses 2018;34:645-56. [PMID: 29732896 DOI: 10.1089/AID.2018.0031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
51 Schwarz RH, Moreno JD. HIV testing: the evolution of a policy. Womens Health Issues 1996;6:109-11. [PMID: 8932465 DOI: 10.1016/1049-3867(96)00001-1] [Reference Citation Analysis]
52 Ewing AC, King CC, Wiener JB, Chasela CS, Hudgens MG, Kamwendo D, Tegha G, Hosseinipour MC, Jamieson DJ, Van der Horst C, Kourtis AP. Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed, uninfected infants. AIDS 2017;31:2455-63. [PMID: 28926409 DOI: 10.1097/QAD.0000000000001641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Proudnikov D, Randesi M, Levran O, Yuferov V, Crystal H, Ho A, Ott J, Kreek MJ. Polymorphisms of the kappa opioid receptor and prodynorphin genes: HIV risk and HIV natural history. J Acquir Immune Defic Syndr 2013;63:17-26. [PMID: 23392455 DOI: 10.1097/QAI.0b013e318285cd0c] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
54 Handforth J, Sharland M. Triple nucleoside reverse transcriptase inhibitor therapy in children. Paediatr Drugs 2004;6:147-59. [PMID: 15170362 DOI: 10.2165/00148581-200406030-00002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
55 Liff I, Zash R, Mingochi D, Gaonakala FT, Diseko M, Mayondi G, Johnson K, James K, Makhema J, Shapiro R, Wylie BJ. Mid-trimester cervical length not associated with HIV status among pregnant women in Botswana. PLoS One 2020;15:e0229500. [PMID: 32160214 DOI: 10.1371/journal.pone.0229500] [Reference Citation Analysis]
56 Cooper DA. World AIDS Day: what progress since last year? Med J Aust 1995;163:566. [PMID: 8538540 DOI: 10.5694/j.1326-5377.1995.tb124751.x] [Reference Citation Analysis]
57 Simonds RJ, Dondero TJ, DeCock KM, Gayle HD. Ethics and HIV trials. Am J Public Health 1999;89:255-6. [PMID: 9949761 DOI: 10.2105/ajph.89.2.255-a] [Reference Citation Analysis]
58 Chen JS, Pence BW, Rahangdale L, Patterson KB, Farel CE, Durr AL, Antono AC, Zakharova O, Eron JJ, Napravnik S. Postpartum HIV care continuum outcomes in the southeastern USA. AIDS 2019;33:637-44. [PMID: 30531320 DOI: 10.1097/QAD.0000000000002094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Arikan Y, Burdge DR. Human immunodeficiency virus infection in pregnancy. Can J Infect Dis 1998;9:301-9. [PMID: 22346550 DOI: 10.1155/1998/274694] [Reference Citation Analysis]
60 Webber MP, Demas P, Blaney N, Cohen MH, Carter R, Lampe M, Jamieson D, Maupin R, Nesheim S, Bulterys M. Correlates of prenatal HIV testing in women with undocumented status at delivery. Matern Child Health J 2008;12:427-34. [PMID: 17968642 DOI: 10.1007/s10995-007-0257-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
61 Moorthy A, Gupta A, Bhosale R, Tripathy S, Sastry J, Kulkarni S, Thakar M, Bharadwaj R, Kagal A, Bhore AV, Patil S, Kulkarni V, Venkataramani V, Balasubramaniam U, Suryavanshi N, Ziemniak C, Gupte N, Bollinger R, Persaud D. Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants. PLoS One 2009;4:e4096. [PMID: 19119321 DOI: 10.1371/journal.pone.0004096] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
62 Hardy E, Cu-Uvin S. Care of the HIV-infected pregnant woman in the developed world. Obstet Med 2015;8:13-7. [PMID: 27512453 DOI: 10.1177/1753495X14531753] [Reference Citation Analysis]
63 Amarakoon II, Ramkissoon A, Pierre R, Eyzaguirre LM, Carr JK, Blattner WA, Roye ME. HIV-1 Antiretroviral Drug Resistance in Pregnant Women in Jamaica: A Preliminary Report. West Indian Med J 2014;63:596-600. [PMID: 25803373 DOI: 10.7727/wimj.2014.016] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
64 Jayasuriya A, Robertson C, Allan PS. Twenty-five years of HIV management. J R Soc Med 2007;100:363-6. [PMID: 17682028 DOI: 10.1177/014107680710000811] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
65 Ishaque S, Yakoob MY, Imdad A, Goldenberg RL, Eisele TP, Bhutta ZA. Effectiveness of interventions to screen and manage infections during pregnancy on reducing stillbirths: a review. BMC Public Health 2011;11 Suppl 3:S3. [PMID: 21501448 DOI: 10.1186/1471-2458-11-S3-S3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
66 Raffe S, Curtis H, Tookey P, Peters H, Freedman A, Gilleece Y; British HIV Association Audit and Standards Sub-Committee. UK national clinical audit: management of pregnancies in women with HIV. BMC Infect Dis 2017;17:158. [PMID: 28219333 DOI: 10.1186/s12879-017-2255-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
67 McCormack SM, Gafos M, Desai M, Cohen MS. Biomedical prevention: state of the science. Clin Infect Dis 2014;59 Suppl 1:S41-6. [PMID: 24926033 DOI: 10.1093/cid/ciu297] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
68 Chersich MF, Gray GE. Progress and Emerging Challenges in Preventing Mother-to-Child Transmission. Curr Infect Dis Rep 2005;7:393-400. [PMID: 16107237 DOI: 10.1007/s11908-005-0014-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
69 Jao J, Hazra R, Mellins CA, Remien RH, Abrams EJ. Disclosing in utero HIV/ARV exposure to the HIV-exposed uninfected adolescent: is it necessary? J Int AIDS Soc 2016;19:21099. [PMID: 27741954 DOI: 10.7448/IAS.19.1.21099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
70 Nicoll A, Peckham C. Reducing vertical transmission of HIV in the UK. BMJ 1999;319:1211-2. [PMID: 10550061 DOI: 10.1136/bmj.319.7219.1211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
71 Keller RD, Nosbisch C, Unadkat JD. Pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) in the neonatal macaque (Macaca nemestrina). Antimicrob Agents Chemother 1995;39:2829-31. [PMID: 8593033 DOI: 10.1128/AAC.39.12.2829] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
72 Parker LA, Jobanputra K, Okello V, Nhlangamandla M, Mazibuko S, Kourline T, Kerschberger B, Pavlopoulos E, Teck R. Implementation and Operational Research: Barriers and Facilitators to Combined ART Initiation in Pregnant Women With HIV: Lessons Learnt From a PMTCT B+ Pilot Program in Swaziland. J Acquir Immune Defic Syndr 2015;69:e24-30. [PMID: 25622060 DOI: 10.1097/QAI.0000000000000537] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
73 Durand-Gasselin L, Pruvost A, Dehée A, Vaudre G, Tabone MD, Grassi J, Leverger G, Garbarg-Chenon A, Bénech H, Dollfus C. High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothers. Antimicrob Agents Chemother 2008;52:2555-63. [PMID: 18426897 DOI: 10.1128/AAC.01130-07] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
74 Brooks KM, Momper JD, Pinilla M, Stek AM, Barr E, Weinberg A, Deville JG, Febo IL, Cielo M, George K, Denson K, Rungruengthanakit K, Shapiro DE, Smith E, Chakhtoura N, Rooney JF, Haubrich R, Espina R, Capparelli EV, Mirochnick M, Best BM; IMPAACT P1026s Protocol Team. Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV. AIDS 2021;35:407-17. [PMID: 33252495 DOI: 10.1097/QAD.0000000000002767] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
75 Joo E, Carmack A, Garcia-Buñuel E, Kelly CJ. Implementation of guidelines for HIV counseling and voluntary HIV testing of pregnant women. Am J Public Health 2000;90:273-6. [PMID: 10667191 DOI: 10.2105/ajph.90.2.273] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
76 Kazeroni PA, Gouya MM, Tira M, Sargolzaiie M, Eybpoosh S, Majdfar Z, Zareie B, Rasouli MA, Ghaderi E. Prevention of mother-to-child HIV transmission program in Iran. BMC Public Health 2021;21:483. [PMID: 33706740 DOI: 10.1186/s12889-021-10520-6] [Reference Citation Analysis]
77 Cerda R, Perez F, Domingues RM, Luz PM, Grinsztejn B, Veloso VG, Caffe S, Francke JA, Freedberg KA, Ciaranello AL. Prenatal Transmission of Syphilis and Human Immunodeficiency Virus in Brazil: Achieving Regional Targets for Elimination. Open Forum Infect Dis 2015;2:ofv073. [PMID: 26180825 DOI: 10.1093/ofid/ofv073] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
78 Smith SL, Chahroudi AM, Camacho-Gonzalez AF, Gillespie S, Wynn BA, Badell ML, Swartzendruber A, Hazra R, Wortley P, Chakraborty R. Evaluating Facility Infrastructure for Prevention of Mother-to-Child Transmission of HIV-A 2015 Assessment of Major Delivery Hospitals in Atlanta, Georgia. J Pediatric Infect Dis Soc 2018;7:e102-6. [PMID: 29986059 DOI: 10.1093/jpids/piy058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Demas PA, Webber MP, Schoenbaum EE, Weedon J, McWayne J, Enriquez E, Bamji M, Lambert G, Thea DM. Maternal adherence to the zidovudine regimen for HIV-exposed infants to prevent HIV infection: a preliminary study. Pediatrics 2002;110:e35. [PMID: 12205285 DOI: 10.1542/peds.110.3.e35] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
80 Schuelter-Trevisol F, Kuehlkamp VM, Biudes MF, Galato D. Mother-to-child transmission of HIV in Brazil: universal access to free antiretroviral therapy. J Acquir Immune Defic Syndr 2012;60:e103-4. [PMID: 22728752 DOI: 10.1097/QAI.0b013e318250f02b] [Reference Citation Analysis]
81 Hoffman RM, Jaycocks A, Vardavas R, Wagner G, Lake JE, Mindry D, Currier JS, Landovitz RJ. Benefits of PrEP as an Adjunctive Method of HIV Prevention During Attempted Conception Between HIV-uninfected Women and HIV-infected Male Partners. J Infect Dis 2015;212:1534-43. [PMID: 26092856 DOI: 10.1093/infdis/jiv305] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
82 De Broucker G, Salvatore PP, Mutembo S, Moyo N, Mutanga JN, Thuma PE, Moss WJ, Sutcliffe CG. The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia. PLoS One 2021;16:e0248217. [PMID: 33690733 DOI: 10.1371/journal.pone.0248217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Nesheim SR, FitzHarris LF, Lampe MA, Gray KM. Reconsidering the Number of Women With HIV Infection Who Give Birth Annually in the United States. Public Health Rep 2018;133:637-43. [PMID: 30265616 DOI: 10.1177/0033354918800466] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
84 Cardenas I, Means RE, Aldo P, Koga K, Lang SM, Booth CJ, Manzur A, Oyarzun E, Romero R, Mor G. Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J Immunol 2010;185:1248-57. [PMID: 20554966 DOI: 10.4049/jimmunol.1000289] [Cited by in Crossref: 156] [Cited by in F6Publishing: 152] [Article Influence: 13.0] [Reference Citation Analysis]
85 Forsyth BW. HIV Infection in Children: A New Hope. Child and Adolescent Psychiatric Clinics of North America 2000;9:279-94. [DOI: 10.1016/s1056-4993(18)30119-6] [Reference Citation Analysis]
86 Puro V, Ippolito G. Newly diagnosed HIV infections among pregnant women and their partners. Eur J Epidemiol 1998;14:521-2. [PMID: 9744688 DOI: 10.1023/a:1007438032448] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
87 Ezeanolue EE, Pharr JR, Hunt A, Patel D, Jackson D. Why are Children Still Being Infected with HIV? Impact of an Integrated Public Health and Clinical Practice Intervention on Mother-to-Child HIV Transmission in Las Vegas, Nevada, 2007-2012. Ann Med Health Sci Res 2015;5:253-9. [PMID: 26229713 DOI: 10.4103/2141-9248.160189] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
88 Rahangdale L, Cates J, Potter J, Badell ML, Seidman D, Miller ES, Coleman JS, Lazenby GB, Levison J, Short WR, Yawetz S, Ciaranello A, Livingston E, Duthely L, Rimawi BH, Anderson JR, Stringer EM; HOPES (HIV OB Pregnancy Education Study) Group. Integrase inhibitors in late pregnancy and rapid HIV viral load reduction. Am J Obstet Gynecol 2016;214:385.e1-7. [PMID: 26928154 DOI: 10.1016/j.ajog.2015.12.052] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
89 Cochrane J. Narrowing the gap: access to HIV treatments in developing countries. A pharmaceutical company's perspective. J Med Ethics 2000;26:47-50; discussion 51-3. [PMID: 10701172 DOI: 10.1136/jme.26.1.47] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
90 Hazra R, Stoszek SK, Freimanis Hance L, Pinto J, Marques H, Peixoto M, Alarcon J, Mussi-Pinhata M, Serchuck L; NISDI Pediatric Study Group 2008. Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries. Int J Epidemiol 2009;38:1207-14. [PMID: 19036797 DOI: 10.1093/ije/dyn239] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
91 Thior I, Gabaitiri L, Grimes J, Shapiro R, Lockman S, Kim S, Kebaabetswe P, Garmey E, Montano M, Peter T, Chang SY, Marlink R, Essex M. Voluntary counseling and testing among post-partum women in Botswana. Patient Educ Couns 2007;65:296-302. [PMID: 17029865 DOI: 10.1016/j.pec.2006.08.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
92 Kapetanovic S, Dass-Brailsford P, Nora D, Talisman N. Mental health of HIV-seropositive women during pregnancy and postpartum period: a comprehensive literature review. AIDS Behav 2014;18:1152-73. [PMID: 24584458 DOI: 10.1007/s10461-014-0728-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
93 Smith DD, Pippen JL, Adesomo AA, Rood KM, Landon MB, Costantine MM. Exclusion of Pregnant Women from Clinical Trials during the Coronavirus Disease 2019 Pandemic: A Review of International Registries. Am J Perinatol 2020;37:792-9. [PMID: 32428965 DOI: 10.1055/s-0040-1712103] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
94 Kumar S. Preventing Mother To Child Transmission of HIV - Current strategies. Med J Armed Forces India 2014;70:307-8. [PMID: 25382901 DOI: 10.1016/j.mjafi.2014.10.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Cartoux M, Meda N, Van de Perre P, Newell ML, de Vincenzi I, Dabis F. Acceptability of voluntary HIV testing by pregnant women in developing countries: an international survey. Ghent International Working Group on Mother-to-Child Transmission of HIV. AIDS 1998;12:2489-93. [PMID: 9875588 DOI: 10.1097/00002030-199818000-00019] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 3.3] [Reference Citation Analysis]
96 Rezk NL, White N, Bridges AS, Abdel-Megeed MF, Mohamed TM, Moselhy SS, Kashuba AD. Studies on antiretroviral drug concentrations in breast milk: validation of a liquid chromatography-tandem mass spectrometric method for the determination of 7 anti-human immunodeficiency virus medications. Ther Drug Monit 2008;30:611-9. [PMID: 18758393 DOI: 10.1097/FTD.0b013e318186e08e] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
97 Nielsen-Saines K, Watts DH, Veloso VG, Bryson YJ, Joao EC, Pilotto JH, Gray G, Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Ceriotto M, Machado D, Bethel J, Morgado MG, Dickover R, Camarca M, Mirochnick M, Siberry G, Grinsztejn B, Moreira RI, Bastos FI, Xu J, Moye J, Mofenson LM; NICHD HPTN 040/PACTG 1043 Protocol Team. Three postpartum antiretroviral regimens to prevent intrapartum HIV infection. N Engl J Med 2012;366:2368-79. [PMID: 22716975 DOI: 10.1056/NEJMoa1108275] [Cited by in Crossref: 140] [Cited by in F6Publishing: 58] [Article Influence: 14.0] [Reference Citation Analysis]
98 Apoola A, tenHof J, Allan PS. Access to infertility investigations and treatment in couples infected with HIV: questionnaire survey. BMJ 2001;323:1285. [PMID: 11731391 DOI: 10.1136/bmj.323.7324.1285] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
99 Pereira LF, Goschin S, Ashley KB. PrEP: A Review for Mental Health Professionals. Journal of Gay & Lesbian Mental Health 2015;20:4-12. [DOI: 10.1080/19359705.2015.1106221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
100 Milligan C, Overbaugh J. The role of cell-associated virus in mother-to-child HIV transmission. J Infect Dis 2014;210 Suppl 3:S631-40. [PMID: 25414417 DOI: 10.1093/infdis/jiu344] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
101 Koenig S, Ivers L, Pace S, Destine R, Leandre F, Grandpierre R, Mukherjee J, Farmer P, Pape J. Successes and challenges of HIV treatment programs in Haiti: aftermath of the earthquake. HIV Ther 2010;4:145-60. [PMID: 21197385 DOI: 10.2217/hiv.10.6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
102 Delicio AM, Lajos GJ, Amaral E, Lopes F, Cavichiolli F, Myioshi I, Milanez H. Adverse effects of antiretroviral therapy in pregnant women infected with HIV in Brazil from 2000 to 2015: a cohort study. BMC Infect Dis 2018;18:485. [PMID: 30261855 DOI: 10.1186/s12879-018-3397-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
103 Nso Roca AP, García-Bermejo CG, Larru B, R M, Muñoz Fernández MA, de José MI. Pathology in children of HIV women. Indian J Pediatr 2009;76:1125-30. [PMID: 20092024 DOI: 10.1007/s12098-009-0225-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
104 Soto-Ramirez LE, Rodriguez-Diaz R, Durán AS, Losso MH, Salomón H, Gómez-Carrillo M, Pampuro S, Harris DR, Duarte G, De Souza RS, Read JS; NISDI Perinatal Study Group. Antiretroviral resistance among HIV type 1-infected women first exposed to antiretrovirals during pregnancy: plasma versus PBMCs. AIDS Res Hum Retroviruses 2008;24:797-804. [PMID: 18507526 DOI: 10.1089/aid.2007.0246] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
105 Alidina Z, Wormsbecker AE, Urquia M, MacGillivray J, Taerk E, Yudin MH, Campbell DM. HIV Prophylaxis in High Risk Newborns: An Examination of Sociodemographic Factors in an Inner City Context. Can J Infect Dis Med Microbiol 2016;2016:2782786. [PMID: 27366161 DOI: 10.1155/2016/2782786] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
106 Ambrosioni J, Calmy A, Hirschel B. HIV treatment for prevention. J Int AIDS Soc 2011;14:28. [PMID: 21612619 DOI: 10.1186/1758-2652-14-28] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
107 Mayer KH, Venkatesh KK. Antiretroviral therapy as HIV prevention: status and prospects. Am J Public Health 2010;100:1867-76. [PMID: 20724682 DOI: 10.2105/AJPH.2009.184796] [Cited by in Crossref: 53] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
108 Anderson BL, Simhan HN, Landers DV. Improving universal prenatal screening for human immunodeficiency virus. Infect Dis Obstet Gynecol 2004;12:115-20. [PMID: 15763910 DOI: 10.1080/10647440400020687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
109 Prestes-Carneiro LE. Antiretroviral therapy, pregnancy, and birth defects: a discussion on the updated data. HIV AIDS (Auckl) 2013;5:181-9. [PMID: 23943659 DOI: 10.2147/HIV.S15542] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
110 Avery R. Immigrant women's health: Infectious diseases - Part 2. West J Med 2001;175:277-9. [PMID: 11577066 DOI: 10.1136/ewjm.175.4.277] [Reference Citation Analysis]
111 Cavalcante MDS, Silveira ÂCBD, Ribeiro AMDS, Ramos Júnior AN. Prevenção da transmissão vertical do vírus da imunodeficiência humana: análise da adesão às medidas de profilaxia em uma maternidade de referência em Fortaleza, Ceará, Brasil. Rev Bras Saude Mater Infant 2008;8:473-9. [DOI: 10.1590/s1519-38292008000400013] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
112 Cardoso T, Kazanji M, Magnan F, Denoyers H, Talarmin A. Risk factors for HIV-1 infection among pregnant women in French Guiana. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:177-9. [PMID: 9241122 DOI: 10.1097/00042560-199706010-00017] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
113 John GC, Nduati RW, Mbori-Ngacha D, Overbaugh J, Welch M, Richardson BA, Ndinya-Achola J, Bwayo J, Krieger J, Onyango F, Kreiss JK. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997;175:57-62. [PMID: 8985196 DOI: 10.1093/infdis/175.1.57] [Cited by in Crossref: 128] [Cited by in F6Publishing: 114] [Article Influence: 5.1] [Reference Citation Analysis]
114 Gruslin A, Salvador A, Dekker M, Menard-de Varennes D, Eason E. Prenatal HIV screening in a tertiary care centre. Can J Public Health 2001;92:255-8. [PMID: 11962108 [PMID: 11962108 DOI: 10.1007/bf03404955] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
115 Leng X, Liang S, Ma Y, Dong Y, Kan W, Goan D, Hsi JH, Liao L, Wang J, He C, Zhang H, Xing H, Ruan Y, Shao Y. HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China. BMJ Open 2014;4:e005886. [PMID: 25319999 DOI: 10.1136/bmjopen-2014-005886] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
116 Edathodu J, Halim MM, Dahham MB, Alrajhi AA. Mother-to-child transmission of HIV: experience at a referral hospital in Saudi Arabia. Ann Saudi Med 2010;30:15-7. [PMID: 20103953 DOI: 10.4103/0256-4947.59367] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Jelicic Kadic A, Kovacevic T, Runjic E, Simicic Majce A, Markic J, Polic B, Mestrovic J, Puljak L. Research methodology used in the 50 most cited articles in the field of pediatrics: types of studies that become citation classics. BMC Med Res Methodol 2020;20:60. [PMID: 32183718 DOI: 10.1186/s12874-020-00940-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Bayer R, Edington C. HIV testing, human rights, and global AIDS policy: exceptionalism and its discontents. J Health Polit Policy Law 2009;34:301-23. [PMID: 19451406 DOI: 10.1215/03616878-2009-002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
119 Baeten JM, Grant R. Use of antiretrovirals for HIV prevention: what do we know and what don't we know? Curr HIV/AIDS Rep 2013;10:142-51. [PMID: 23494772 DOI: 10.1007/s11904-013-0157-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
120 Powis KM, Lockman S, Ajibola G, Hughes MD, Bennett K, Leidner J, Batlang O, Botebele K, Moyo S, van Widenfelt E, Makhema J, Petlo C, Jibril HB, McIntosh K, Essex M, Shapiro RL. Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana. South Afr J HIV Med 2018;19:751. [PMID: 29707385 DOI: 10.4102/sajhivmed.v19i1.751] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
121 McDougal SJ, Alexander J, Dhanireddy S, Harrington RD, Stekler JD. Non-occupational post-exposure prophylaxis for HIV: 10-year retrospective analysis in Seattle, Washington. PLoS One 2014;9:e105030. [PMID: 25140868 DOI: 10.1371/journal.pone.0105030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
122 Koch AL. Stone age diseases and modern AIDS. Virol J 2008;5:93. [PMID: 18687115 DOI: 10.1186/1743-422X-5-93] [Reference Citation Analysis]
123 Herbst JH, Glassman M, Carey JW, Painter TM, Gelaude DJ, Fasula AM, Raiford JL, Freeman AE, Harshbarger C, Viall AH, Purcell DW. Operational research to improve HIV prevention in the United States. J Acquir Immune Defic Syndr 2012;59:530-6. [PMID: 22217681 DOI: 10.1097/QAI.0b013e3182479077] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
124 Reiss G, O'Brien M, Kopicko J, Clark RA. Lack of association between pregnancy and selected gastrointestinal adverse events among women prescribed nelfinavir. J Acquir Immune Defic Syndr 2001;26:513-4. [PMID: 11391176 DOI: 10.1097/00126334-200104150-00021] [Reference Citation Analysis]
125 Mugwanya KK, Baeten JM. Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention. Expert Opin Drug Saf 2016;15:265-73. [PMID: 26634852 DOI: 10.1517/14740338.2016.1128412] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
126 Katz IT, Shapiro R, Li D, Govindarajulu U, Thompson B, Watts DH, Hughes MD, Tuomala R. Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study. J Acquir Immune Defic Syndr 2010;54:27-34. [PMID: 20065861 DOI: 10.1097/QAI.0b013e3181caea89] [Cited by in Crossref: 37] [Cited by in F6Publishing: 13] [Article Influence: 3.1] [Reference Citation Analysis]
127 Scott JB. The public policy debate over newborn HIV testing: A case study of the knowledge enthymeme. Rhetoric Society Quarterly 2002;32:57-83. [DOI: 10.1080/02773940209391228] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
128 Lalani T, Hicks C. Does antiretroviral therapy prevent HIV transmission to sexual partners? Curr Infect Dis Rep 2008;10:140-5. [PMID: 18462589 DOI: 10.1007/s11908-008-0025-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
129 McDonald K, Amir LH, Davey MA. Maternal bodies and medicines: a commentary on risk and decision-making of pregnant and breastfeeding women and health professionals. BMC Public Health 2011;11 Suppl 5:S5. [PMID: 22168473 DOI: 10.1186/1471-2458-11-S5-S5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
130 Newell ML, Gibb DM. A risk-benefit assessment of zidovudine in the prevention of perinatal HIV transmission. Drug Saf 1995;12:274-82. [PMID: 7646826 DOI: 10.2165/00002018-199512040-00007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
131 Royce RA, Walter EB, Fernandez MI, Wilson TE, Ickovics JR, Simonds RJ; Perinatal Guidelines Evaluation Project. Barriers to universal prenatal HIV testing in 4 US locations in 1997. Am J Public Health 2001;91:727-33. [PMID: 11344880 DOI: 10.2105/ajph.91.5.727] [Cited by in Crossref: 37] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
132 Malee KM, Mellins CA, Huo Y, Tassiopoulos K, Smith R, Sirois PA, Allison SM, Kacanek D, Kapetanovic S, Williams PL, Grant ML, Marullo D, Aidala AA; Pediatric HIVAIDS Cohort Study (PHACS). Prevalence, incidence, and persistence of psychiatric and substance use disorders among mothers living with HIV. J Acquir Immune Defic Syndr 2014;65:526-34. [PMID: 24759063 DOI: 10.1097/QAI.0000000000000070] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
133 Divi RL, Einem TL, Fletcher SL, Shockley ME, Kuo MM, St Claire MC, Cook A, Nagashima K, Harbaugh SW, Harbaugh JW, Poirier MC. Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs). Toxicol Sci 2010;118:191-201. [PMID: 20702595 DOI: 10.1093/toxsci/kfq235] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
134 Neely M, Kovacs A. Management of Antiretroviral Therapy in Neonates, Children, and Adolescents. Curr Infect Dis Rep 2003;5:521-30. [PMID: 14642195 DOI: 10.1007/s11908-003-0097-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
135 Gupta RK, Van de Vijver DA, Manicklal S, Wainberg MA. Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention. Retrovirology 2013;10:82. [PMID: 23902855 DOI: 10.1186/1742-4690-10-82] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
136 Van Rompay KK, Miller MD, Marthas ML, Margot NA, Dailey PJ, Canfield DR, Tarara RP, Cherrington JM, Aguirre NL, Bischofberger N, Pedersen NC. Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA. J Virol 2000;74:1767-74. [PMID: 10644348 DOI: 10.1128/jvi.74.4.1767-1774.2000] [Cited by in Crossref: 59] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
137 Krakovka S, Ranjbarian F, Luján LA, Saura A, Larsen NB, Jiménez-González A, Reggenti A, Luján HD, Svärd SG, Hofer A. Giardia intestinalis thymidine kinase is a high-affinity enzyme crucial for DNA synthesis and an exploitable target for drug discovery. J Biol Chem 2022;:102028. [PMID: 35568200 DOI: 10.1016/j.jbc.2022.102028] [Reference Citation Analysis]
138 Cordeiro CN, Tsimis M, Burd I. Infections and Brain Development. Obstet Gynecol Surv 2015;70:644-55. [PMID: 26490164 DOI: 10.1097/OGX.0000000000000236] [Cited by in Crossref: 60] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
139 Puro V, D'Ubaldo C, Aloisi MS, Sherr L, Ippolito G. Temporal trends in reasons for and result of HIV-testing among women in Rome, Italy. Eur J Epidemiol 1998;14:433-7. [PMID: 9744674 DOI: 10.1023/a:1007422714701] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
140 Martinez DR, Vandergrift N, Douglas AO, McGuire E, Bainbridge J, Nicely NI, Montefiori DC, Tomaras GD, Fouda GG, Permar SR. Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk. J Virol 2017;91:e02422-16. [PMID: 28202762 DOI: 10.1128/JVI.02422-16] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
141 Swindells S, Flexner C, Fletcher CV, Jacobson JM. The critical need for alternative antiretroviral formulations, and obstacles to their development. J Infect Dis 2011;204:669-74. [PMID: 21788451 DOI: 10.1093/infdis/jir370] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
142 Wang G, Izadpanah N, Kitchen CM, Bernstein HB. Fetal allostimulation of maternal cells: a potential mechanism for perinatal HIV transmission following obstetrical hemorrhage. AIDS Res Hum Retroviruses 2008;24:1545-54. [PMID: 19102686 DOI: 10.1089/aid.2008.0007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
143 Schevis S. The challenge of providing choices to women. J Assoc Nurses AIDS Care 1996;7:13. [PMID: 8825176 DOI: 10.1016/S1055-3290(96)80033-1] [Reference Citation Analysis]
144 Kumar SB, Rice CE, Milner DA Jr, Ramirez NC, Ackerman WE 4th, Mwapasa V, Turner AN, Kwiek JJ. Elevated cytokine and chemokine levels in the placenta are associated with in-utero HIV-1 mother-to-child transmission. AIDS 2012;26:685-94. [PMID: 22301415 DOI: 10.1097/QAD.0b013e3283519b00] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
145 Buchholz B, Beichert M, Marcus U, Grubert T, Gingelmaier A, Haberl A, Schmied B; German AIDS Society., Austrian AIDS Society., HIV-AIDS Competence Network., Robert-Koch Institute Berlin., German Association of Physicians Specialized in HIV Care., German Society of Pediatric and Youth Medicine., German AIDS Pediatric Association., German Society of Obstetrics and Gynecology., National Reference Center for Retroviruses., German AIDS Assistance. German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008. Eur J Med Res 2009;14:461-79. [PMID: 19948442 DOI: 10.1186/2047-783x-14-11-461] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
146 Grant RM, Kuritzkes DR, Johnson VA, Mellors JW, Sullivan JL, Swanstrom R, D'Aquila RT, Van Gorder M, Holodniy M, Lloyd RM Jr, Reid C, Morgan GF, Winslow DL. Accuracy of the TRUGENE HIV-1 genotyping kit. J Clin Microbiol 2003;41:1586-93. [PMID: 12682149 DOI: 10.1128/JCM.41.4.1586-1593.2003] [Cited by in Crossref: 87] [Cited by in F6Publishing: 53] [Article Influence: 4.6] [Reference Citation Analysis]
147 Vermund SH, Hayes RJ. Combination prevention: new hope for stopping the epidemic. Curr HIV/AIDS Rep 2013;10:169-86. [PMID: 23456730 DOI: 10.1007/s11904-013-0155-y] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 6.6] [Reference Citation Analysis]
148 Van Dyke RB, Patel K, Siberry GK, Burchett SK, Spector SA, Chernoff MC, Read JS, Mofenson LM, Seage GR 3rd; Pediatric HIV/AIDS Cohort Study. Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes. J Acquir Immune Defic Syndr 2011;57:165-73. [PMID: 21407086 DOI: 10.1097/QAI.0b013e318215c7b1] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 5.2] [Reference Citation Analysis]
149 Stringer EM, Chi BH, Chintu N, Creek TL, Ekouevi DK, Coetzee D, Tih P, Boulle A, Dabis F, Shaffer N, Wilfert CM, Stringer JS. Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lower-income countries. Bull World Health Organ 2008;86:57-62. [PMID: 18235891 DOI: 10.2471/blt.07.043117] [Cited by in Crossref: 88] [Cited by in F6Publishing: 61] [Article Influence: 6.3] [Reference Citation Analysis]
150 Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, McIntyre J, Gnanashanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM; IMPAACT 1077BF/1077FF PROMISE Study Team. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. N Engl J Med 2016;375:1726-37. [PMID: 27806243 DOI: 10.1056/NEJMoa1511691] [Cited by in Crossref: 172] [Cited by in F6Publishing: 95] [Article Influence: 28.7] [Reference Citation Analysis]
151 Blanche S. Mini review: Prevention of mother-child transmission of HIV: 25 years of continuous progress toward the eradication of pediatric AIDS? Virulence 2020;11:14-22. [PMID: 31885324 DOI: 10.1080/21505594.2019.1697136] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
152 Rongkavilit C, Thaithumyanon P, Chuenyam T, Damle BD, Limpongsanurak S, Boonrod C, Srigritsanapol A, Hassink EA, Hoetelmans RM, Cooper DA, Lange JM, Ruxrungtham K, Phanuphak P. Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates. Antimicrob Agents Chemother 2001;45:3585-90. [PMID: 11709344 DOI: 10.1128/AAC.45.12.3585-3590.2001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
153 Ciaranello AL, Perez F, Engelsmann B, Walensky RP, Mushavi A, Rusibamayila A, Keatinge J, Park JE, Maruva M, Cerda R, Wood R, Dabis F, Freedberg KA. Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe. Clin Infect Dis 2013;56:430-46. [PMID: 23204035 DOI: 10.1093/cid/cis858] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
154 Guimarães MF, Lovero KL, de Avelar JG, Pires LL, de Oliveira GRT, Cosme EM, de Morais Salviato C, de Oliveira TRD, Cabrera NB, Cardoso CAA. Review of the missed opportunities for the prevention of vertical transmission of HIV in Brazil. Clinics (Sao Paulo) 2019;74:e318. [PMID: 31531571 DOI: 10.6061/clinics/2019/e318] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
155 Luzuriaga K. Mother-to-child transmission of HIV: a global perspective. Curr Infect Dis Rep 2007;9:511-7. [PMID: 17999887 DOI: 10.1007/s11908-007-0076-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
156 Fauchet F, Treluyer JM, Valade E, Benaboud S, Pannier E, Firtion G, Foissac F, Bouazza N, Urien S, Hirt D. Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour? Br J Clin Pharmacol 2014;78:1387-96. [PMID: 25040510 DOI: 10.1111/bcp.12459] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
157 Hoover DR, Doherty MC, Vlahov D, Miotti P. Incidence and risk factors for HIV-1 infection—a summary of what is known and the psychiatric relevance. International Review of Psychiatry 2009;8:137-48. [DOI: 10.3109/09540269609046298] [Reference Citation Analysis]
158 Ethier KA, Fox-Tierney R, Nicholas WC, Salisbury KM, Ickovics JR. Organizational predictors of prenatal HIV counseling and testing. Am J Public Health 2000;90:1448-51. [PMID: 10983205 DOI: 10.2105/ajph.90.9.1448] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
159 Mitchell C, Roemer E, Nkwopara E, Robbins B, Cory T, Rue T, Fletcher CV, Frenkel L. Correlation between plasma, intracellular, and cervical tissue levels of raltegravir at steady-state dosing in healthy women. Antimicrob Agents Chemother 2014;58:3360-5. [PMID: 24687503 DOI: 10.1128/AAC.02757-13] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
160 Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, Osmond DH. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 2004;18:81-8. [PMID: 15090833 DOI: 10.1097/00002030-200401020-00010] [Cited by in Crossref: 202] [Cited by in F6Publishing: 192] [Article Influence: 11.2] [Reference Citation Analysis]
161 Kuhn L, Sinkala M, Thea DM, Kankasa C, Aldrovandi GM. HIV prevention is not enough: child survival in the context of prevention of mother to child HIV transmission. J Int AIDS Soc 2009;12:36. [PMID: 20015345 DOI: 10.1186/1758-2652-12-36] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
162 Van Rompay KKA. Tackling HIV and AIDS: contributions by non-human primate models. Lab Anim (NY) 2017;46:259-70. [PMID: 28530684 DOI: 10.1038/laban.1279] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
163 Truong HM, Sim MS, Dillon M, Uittenbogaart CH, Dickover R, Plaeger SF, Bryson YJ. Correlation of immune activation during late pregnancy and early postpartum with increases in plasma HIV RNA, CD4/CD8 T cells, and serum activation markers. Clin Vaccine Immunol 2010;17:2024-8. [PMID: 20980480 DOI: 10.1128/CVI.00088-10] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
164 Scott GB, Brogly SB, Muenz D, Stek AM, Read JS; International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1025 Study Team. Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus. Obstet Gynecol 2017;129:621-8. [PMID: 28277349 DOI: 10.1097/AOG.0000000000001929] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 3.6] [Reference Citation Analysis]
165 Zahedi-Spung L, Young M, Haddad LB, Badell ML. Perceived Barriers to Antepartum HIV Medication Adherence in HIV Infected Pregnant Women. Infect Dis Obstet Gynecol 2018;2018:4049212. [PMID: 30410301 DOI: 10.1155/2018/4049212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
166 Schäfer A. Materno-fetal transmission of human immune deficiency virus. Infect Dis Obstet Gynecol 1997;5:115-20. [PMID: 18476163 DOI: 10.1155/S1064744997000185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
167 Trotta M, Meli M, Ginelli R, Sbaragli S, Leoncini F. Antiretroviral therapy in pregnant women of Florence. Int J Infect Dis 2001;5:230-1. [PMID: 11953225 DOI: 10.1016/s1201-9712(01)90079-7] [Reference Citation Analysis]
168 Paintsil E, Andiman WA. Update on successes and challenges regarding mother-to-child transmission of HIV. Curr Opin Pediatr. 2009;21:94-101. [PMID: 19242245 DOI: 10.1097/MOP.0b013e32831ec353] [Cited by in Crossref: 74] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
169 Goldie RL, De Matteo DJ, Wells LM, Aykroyd GR, King SM. Social planning in Canada for families with HIV infection. Can J Public Health 2000;91:353-6. [PMID: 11089288 [PMID: 11089288 DOI: 10.1007/bf03404806] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
170 Peters VB, Liu KL, Robinson LG, Dominguez KL, Abrams EJ, Gill BS, Thomas PA. Trends in perinatal HIV prevention in New York City, 1994-2003. Am J Public Health 2008;98:1857-64. [PMID: 18309139 DOI: 10.2105/AJPH.2007.110023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
171 Theilgaard ZP, Chiduo MG, Flamholc L, Gerstoft J, Bygbjerg IC, Lemnge MM, Katzenstein TL. Retired Nurses Can Improve Retention in Prevention of Mother-to-Child Transmission Programmes. East Afr Health Res J 2019;3:88-95. [PMID: 34308201 DOI: 10.24248/EAHRJ-D-19-00011] [Reference Citation Analysis]
172 Garland SM, Duke JE, Woodhouse DR. Antenatal screening for HIV in Australia: time to revise policies? Medical Journal of Australia 2000;172:188-9. [DOI: 10.5694/j.1326-5377.2000.tb125552.x] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
173 Powis KM, Huo Y, Williams PL, Kacanek D, Jao J, Patel K, Seage GR 3rd, Van Dyke RB, Chadwick EG; Pediatric HIV/AIDS Cohort Study (PHACS). Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017. JAMA Netw Open 2019;2:e1917669. [PMID: 31851347 DOI: 10.1001/jamanetworkopen.2019.17669] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
174 Bowie WR. Drug therapies for sexually transmitted diseases. Clinical and economic considerations. Drugs 1995;49:496-515. [PMID: 7789285 DOI: 10.2165/00003495-199549040-00002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
175 Tricoire J, Claeyssens S, Berrebi A, Izopet J, Rolland M. [Early hematological consequences in infants born to HIV seropositive mothers treated with zidovudine during pregnancy]. Arch Pediatr 1995;2:800-1. [PMID: 7550849 DOI: 10.1016/0929-693x(96)81254-1] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
176 Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, Osmond DH. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 2004;18:81-8. [PMID: 15090833 DOI: 10.1097/00002030-200401020-00010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
177 Giaquinto C, Penazzato M, Rosso R, Bernardi S, Rampon O, Nasta P, Ammassari A, Antinori A, Badolato R, Castelli Gattinara G, d'Arminio Monforte A, De Martino M, De Rossi A, Di Gregorio P, Esposito S, Fatuzzo F, Fiore S, Franco A, Gabiano C, Galli L, Genovese O, Giacomet V, Giannattasio A, Gotta C, Guarino A, Martino A, Mazzotta F, Principi N, Regazzi MB, Rossi P, Russo R, Saitta M, Salvini F, Trotta S, Viganò A, Zuccotti G, Carosi G; Italian Paediatric HIV Infection Working Group. Italian consensus statement on paediatric HIV infection. Infection 2010;38:301-19. [PMID: 20514509 DOI: 10.1007/s15010-010-0020-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
178 Willocks L. Transmission of HIV infection from mother to child. Lancet 1996;348:763-4. [PMID: 8806329 DOI: 10.1016/S0140-6736(05)65683-8] [Reference Citation Analysis]
179 Goldstein PJ, Smit R, Stevens M, Sever JL. Association between HIV in pregnancy and antiretroviral therapy, including protease inhibitors and low birth weight infants. Infect Dis Obstet Gynecol 2000;8:94-8. [PMID: 10805364 DOI: 10.1002/(SICI)1098-0997(2000)8:2<94::AID-IDOG6>3.0.CO;2-V] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
180 Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BQ, Li AM, Shi MF, Zou L. Interruption of HBV intrauterine transmission: A clinical study. World J Gastroenterol 2003; 9(7): 1501-1503 [PMID: 12854150 DOI: 10.3748/wjg.v9.i7.1501] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 83] [Article Influence: 4.5] [Reference Citation Analysis]
181 Akhigbe RE, Bamidele JO. Prevalence and pattern of utilization of voluntary counseling and testing services and HIV infection in Ogbomoso, southwestern Nigeria. J Nat Sci Biol Med 2013;4:163-6. [PMID: 23633855 DOI: 10.4103/0976-9668.107283] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
182 Mouillet JF, Ouyang Y, Bayer A, Coyne CB, Sadovsky Y. The role of trophoblastic microRNAs in placental viral infection. Int J Dev Biol 2014;58:281-9. [PMID: 25023694 DOI: 10.1387/ijdb.130349ys] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
183 Broder S. The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antiviral Res 2010;85:1-18. [PMID: 20018391 DOI: 10.1016/j.antiviral.2009.10.002] [Cited by in Crossref: 280] [Cited by in F6Publishing: 243] [Article Influence: 21.5] [Reference Citation Analysis]
184 Rychert J, Lacour N, Amedee AM. Genetic analysis of simian immunodeficiency virus expressed in milk and selectively transmitted through breastfeeding. J Virol 2006;80:3721-31. [PMID: 16571789 DOI: 10.1128/JVI.80.8.3721-3731.2006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
185 Masters MC, Krueger KM, Williams JL, Morrison L, Cohn SE. Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States. Expert Rev Clin Pharmacol 2019;12:1129-43. [PMID: 31774001 DOI: 10.1080/17512433.2019.1698946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
186 Socías ME, Hermida L, Singman M, Kulgis G, Díaz Armas A, Cando O, Sued O, Pérez H, Hermes R, Presas JL, Cahn P. Routine HIV testing among hospitalized patients in Argentina. is it time for a policy change? PLoS One 2013;8:e69517. [PMID: 23936034 DOI: 10.1371/journal.pone.0069517] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
187 Zheng Y, Hirt D, Delmas S, Lui G, Benaboud S, Lechedanec J, Tréluyer JM, Chenevier-Gobeaux C, Arezes E, Gelley A, Amri I, Urien S, Bouazza N, Foissac F, Warszawski J, Ghosn J. Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial. Antimicrob Agents Chemother 2020;64:e00759-20. [PMID: 32661003 DOI: 10.1128/AAC.00759-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
188 Lalonde MS, Troyer RM, Syed AR, Bulime S, Demers K, Bajunirwe F, Arts EJ. Sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispecies. J Clin Microbiol 2007;45:2604-15. [PMID: 17567789 DOI: 10.1128/JCM.00431-07] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
189 Cafferkey M, Philbin M, McDonnell E, McKenna P. Screening for HIV-1 in pregnancy. Lancet 1998;351:1893-4. [PMID: 9652707 DOI: 10.1016/S0140-6736(05)78851-6] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
190 Granich R, Gupta S, Suthar AB, Smyth C, Hoos D, Vitoria M, Simao M, Hankins C, Schwartlander B, Ridzon R, Bazin B, Williams B, Lo YR, McClure C, Montaner J, Hirnschall G; ART in Prevention of HIV and TB Research Writing Group. Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr HIV Res 2011;9:446-69. [PMID: 21999779 DOI: 10.2174/157016211798038597] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 7.2] [Reference Citation Analysis]
191 Weinberg A, Forster-Harwood J, Davies J, McFarland EJ, Pappas J, Kinzie K, Barr E, Paul S, Salbenblatt C, Soda E, Vazquez A, Levin MJ. Safety and tolerability of antiretrovirals during pregnancy. Infect Dis Obstet Gynecol 2011;2011:867674. [PMID: 21603231 DOI: 10.1155/2011/867674] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
192 Novick LF. A remarkable public health achievement: reduction in mother-to-child transmission of HIV. J Public Health Manag Pract 2010;16:479-80. [PMID: 20885176 DOI: 10.1097/PHH.0b013e3181f7cd54] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
193 . 5.0 Use of antiretroviral therapy in pregnancy: BHIVA guidelines for the management of HIV infection in pregnant women 2012. HIV Med 2012;13:103-12. [DOI: 10.1111/j.1468-1293.2012.1030_6.x] [Reference Citation Analysis]
194 Lampe MA. Human immunodeficiency virus-1 and preconception care. Matern Child Health J 2006;10:S193-5. [PMID: 16832609 DOI: 10.1007/s10995-006-0131-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
195 Cowan FM, French R, Johnson AM. The role and effectiveness of partner notification in STD control: a review. Genitourin Med 1996;72:247-52. [PMID: 8976827 DOI: 10.1136/sti.72.4.247] [Cited by in Crossref: 9] [Cited by in F6Publishing: 29] [Article Influence: 0.4] [Reference Citation Analysis]
196 Darak S, Panditrao M, Parchure R, Kulkarni V, Kulkarni S, Janssen F. Systematic review of public health research on prevention of mother-to-child transmission of HIV in India with focus on provision and utilization of cascade of PMTCT services. BMC Public Health 2012;12:320. [PMID: 22550955 DOI: 10.1186/1471-2458-12-320] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
197 Sripan P, Le Coeur S, Amzal B, Ingsrisawang L, Traisathit P, Ngo-Giang-Huong N, McIntosh K, Cressey TR, Sangsawang S, Rawangban B, Kanjanavikai P, Tréluyer JM, Jourdain G, Lallemant M, Urien S. Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PLoS One 2015;10:e0126647. [PMID: 25992639 DOI: 10.1371/journal.pone.0126647] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
198 Remis RS, Merid MF, Palmer RW, Whittingham E, King SM, Danson NS, Vernich L, Swantee C, Major C. High uptake of HIV testing in pregnant women in Ontario, Canada. PLoS One. 2012;7:e48077. [PMID: 23152762 DOI: 10.1371/journal.pone.0048077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
199 Jao J, Abrams EJ. Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants. Pediatr Infect Dis J 2014;33:734-40. [PMID: 24378947 DOI: 10.1097/INF.0000000000000224] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
200 Newell ML, Huang S, Fiore S, Thorne C, Mandelbrot L, Sullivan JL, Maupin R, Delke I, Watts DH, Gelber RD, Cunningham CK; PACTG 316 Study Team. Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA. BMC Infect Dis 2007;7:60. [PMID: 17584491 DOI: 10.1186/1471-2334-7-60] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
201 Hoenerhoff MJ, Hong HH, Ton TV, Lahousse SA, Sills RC. A review of the molecular mechanisms of chemically induced neoplasia in rat and mouse models in National Toxicology Program bioassays and their relevance to human cancer. Toxicol Pathol 2009;37:835-48. [PMID: 19846892 DOI: 10.1177/0192623309351726] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
202 Olivero OA. Relevance of experimental models for investigation of genotoxicity induced by antiretroviral therapy during human pregnancy. Mutat Res 2008;658:184-90. [PMID: 18295533 DOI: 10.1016/j.mrrev.2007.12.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
203 New York City Department of Health HIV Epidemiology Group. 25 years of HIV in New York City: lessons from surveillance. J Urban Health 2001;78:669-78. [PMID: 11796813 DOI: 10.1093/jurban/78.4.669] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
204 Winters MA, Van Rompay KK, Kashuba AD, Shulman NS, Holodniy M. Maternal-fetal pharmacokinetics and dynamics of a single intrapartum dose of maraviroc in rhesus macaques. Antimicrob Agents Chemother 2010;54:4059-63. [PMID: 20696881 DOI: 10.1128/AAC.00747-10] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
205 Dryden-Peterson S, Shapiro RL, Hughes MD, Powis K, Ogwu A, Moffat C, Moyo S, Makhema J, Essex M, Lockman S. Increased risk of severe infant anemia after exposure to maternal HAART, Botswana. J Acquir Immune Defic Syndr 2011;56:428-36. [PMID: 21266910 DOI: 10.1097/QAI.0b013e31820bd2b6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
206 Iwuji CC, McGrath N, de Oliveira T, Porter K, Pillay D, Fisher M, Newport M, Newell ML. The Art of HIV Elimination: Past and Present Science. J AIDS Clin Res 2015;6:525. [PMID: 27774350 DOI: 10.4172/2155-6113.1000525] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
207 Sturt AS, Anglemyer A, Berk DR, Maldonado YA. Temporal trends in mucocutaneous findings among human immunodeficiency virus 1-infected children in a population-based cohort. Pediatr Dermatol 2013;30:451-6. [PMID: 23131130 DOI: 10.1111/pde.12020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
208 Castel AD, Magnus M, Greenberg AE. Update on the Epidemiology and Prevention of HIV/AIDS in the United States. Curr Epidemiol Rep 2015;2:110-9. [PMID: 25960941 DOI: 10.1007/s40471-015-0042-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
209 Archibald CP. HIV/AIDS--the new "great teacher". Can J Public Health 1997;88:11-3. [PMID: 9094797 [PMID: 9094797 DOI: 10.1007/bf03403850] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
210 Bakardjiev AI, Stacy BA, Fisher SJ, Portnoy DA. Listeriosis in the pregnant guinea pig: a model of vertical transmission. Infect Immun 2004;72:489-97. [PMID: 14688130 DOI: 10.1128/IAI.72.1.489-497.2004] [Cited by in Crossref: 100] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
211 Chagomerana MB, Miller WC, Tang JH, Hoffman IF, Mthiko BC, Phulusa J, John M, Jumbe A, Hosseinipour MC. Optimizing prevention of HIV mother to child transmission: Duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women. PLoS One 2018;13:e0195033. [PMID: 29614083 DOI: 10.1371/journal.pone.0195033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
212 Swenson RR, Rizzo CJ, Brown LK, Vanable PA, Carey MP, Valois RF, DiClemente RJ, Romer D. HIV knowledge and its contribution to sexual health behaviors of low-income African American adolescents. J Natl Med Assoc 2010;102:1173-82. [PMID: 21287898 DOI: 10.1016/s0027-9684(15)30772-0] [Cited by in Crossref: 60] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
213 Şahin B, Şahin B, Şahin GC. Sexually Transmitted Infections in Pregnancy, Screening and Treatment. Curr Obstet Gynecol Rep 2022;11:34-43. [DOI: 10.1007/s13669-021-00318-z] [Reference Citation Analysis]
214 Shearer WT, Duliege AM, Kline MW, Hammill H, Minkoff H, Ammann AJ, Chen S, Izu A, Mordenti J. Transport of recombinant human CD4-immunoglobulin G across the human placenta: pharmacokinetics and safety in six mother-infant pairs in AIDS clinical trial group protocol 146. Clin Diagn Lab Immunol 1995;2:281-5. [PMID: 7664172 DOI: 10.1128/cdli.2.3.281-285.1995] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
215 Merchant RC, Mayer KH, Browning CA. Development of guidelines on nonoccupational HIV postexposure prophylaxis for the state of Rhode Island. Public Health Rep 2004;119:136-40. [PMID: 15192899 DOI: 10.1177/003335490411900205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
216 Patel M, Tedaldi E, Armon C, Nesheim S, Lampe M, Palella F Jr, Novak R, Sutton M, Buchacz K; HOPS Investigators. HIV RNA Suppression during and after Pregnancy among Women in the HIV Outpatient Study, 1996 to 2015. J Int Assoc Provid AIDS Care 2018;17:2325957417752259. [PMID: 29357772 DOI: 10.1177/2325957417752259] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
217 Fitting S, Booze RM, Mactutus CF. HIV-1 proteins, Tat and gp120, target the developing dopamine system. Curr HIV Res 2015;13:21-42. [PMID: 25613135 DOI: 10.2174/1570162x13666150121110731] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
218 Murdaca G, Costantini S, Villa R, Setti M, Puppo F, Indiveri F. A case of transposition of the great arteries in a female infant of a HIV-1-infected woman. Potential teratogenic effects of antiretroviral drugs. Intern Emerg Med 2006;1:86-8. [PMID: 16941823 DOI: 10.1007/BF02934732] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
219 Lala MM, Merchant RH. Prevention on parent to child transmission of HIV - what is new? Indian J Pediatr 2012;79:1491-500. [PMID: 23080266 DOI: 10.1007/s12098-012-0887-5] [Reference Citation Analysis]
220 Chen YQ, Peng L, Wang Y, Appelmans E, Dasgupta S, Fleming TR. Trial designs for evaluating combination HIV prevention approaches. HIV Res Clin Pract 2020;21:72-82. [PMID: 32698705 DOI: 10.1080/25787489.2020.1798083] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
221 Kuhn L, Kasonde P, Sinkala M, Kankasa C, Semrau K, Scott N, Tsai WY, Vermund SH, Aldrovandi GM, Thea DM. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis 2005;41:1654-61. [PMID: 16267740 DOI: 10.1086/498029] [Cited by in Crossref: 129] [Cited by in F6Publishing: 127] [Article Influence: 7.6] [Reference Citation Analysis]
222 Delaugerre C, Chaix ML, Blanche S, Warszawski J, Cornet D, Dollfus C, Schneider V, Burgard M, Faye A, Mandelbrot L, Tubiana R, Rouzioux C; ANRS French Perinatal Cohort. Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome. Retrovirology 2009;6:85. [PMID: 19765313 DOI: 10.1186/1742-4690-6-85] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
223 Millum J, Grady C, Keusch G, Sina B. Introduction: the Fogarty International Research Ethics Education and Curriculum Development Program in historical context. J Empir Res Hum Res Ethics 2013;8:3-16. [PMID: 24384512 DOI: 10.1525/jer.2013.8.5.3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
224 Rovira N, Noguera-Julian A, Rives S, Berrueco R, Lahoz R, Fortuny C. Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infants. Eur J Pediatr 2016;175:1013-7. [PMID: 27165499 DOI: 10.1007/s00431-016-2730-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
225 Resti M, Azzari C, Bortolotti F. Hepatitis C virus infection in children coinfected with HIV: epidemiology and management. Paediatr Drugs 2002;4:571-80. [PMID: 12175272 DOI: 10.2165/00128072-200204090-00003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
226 Ward RM. Pharmacological treatment of the fetus. Clinical pharmacokinetic considerations. Clin Pharmacokinet 1995;28:343-50. [PMID: 7614774 DOI: 10.2165/00003088-199528050-00001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
227 Ubesie AC. Pediatric HIV/AIDS in sub-Saharan Africa: emerging issues and way forward. Afr Health Sci 2012;12:297-304. [PMID: 23382743 DOI: 10.4314/ahs.v12i3.8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
228 Coates TJ, Kulich M, Celentano DD, Zelaya CE, Chariyalertsak S, Chingono A, Gray G, Mbwambo JK, Morin SF, Richter L, Sweat M, van Rooyen H, McGrath N, Fiamma A, Laeyendecker O, Piwowar-Manning E, Szekeres G, Donnell D, Eshleman SH; NIMH Project Accept (HPTN 043) study team. Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial. Lancet Glob Health 2014;2:e267-77. [PMID: 25103167 DOI: 10.1016/S2214-109X(14)70032-4] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 12.9] [Reference Citation Analysis]
229 Tarasova O, Poroikov V, Veselovsky A. Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review. Molecules 2018;23:E1233. [PMID: 29883406 DOI: 10.3390/molecules23051233] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
230 Lewis W. Absence of cardiac toxicity of zidovudine in infants. N Engl J Med 2001;344:458. [PMID: 11221608 DOI: 10.1056/NEJM200102083440613] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
231 Moreira-Silva SF, Zandonade E, Miranda AE. Mortality in children and adolescents vertically infected by HIV receiving care at a referral hospital in Vitoria, Brazil. BMC Infect Dis 2015;15:155. [PMID: 25888439 DOI: 10.1186/s12879-015-0893-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
232 Bessoff K, Sateriale A, Lee KK, Huston CD. Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth. Antimicrob Agents Chemother 2013;57:1804-14. [PMID: 23380723 DOI: 10.1128/AAC.02460-12] [Cited by in Crossref: 86] [Cited by in F6Publishing: 54] [Article Influence: 9.6] [Reference Citation Analysis]
233 Koh M, Shinohara J, Hongo Y, Okazaki T, Takitani K, Tamai H. Case treated with triple therapy of lamivudine, interferon-β and prednisolone for acute exacerbation of chronic hepatitis B during pregnancy. Hepatol Res. 2013;43:425-429. [PMID: 23560863 DOI: 10.1111/j.1872-034x.2012.01077.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
234 Zucker A. Law and ethics. Death Studies 1995;19:293-8. [DOI: 10.1080/07481189508252733] [Reference Citation Analysis]
235 Perez-then E. Newborn treatment with nevirapine plus zidovudine reduces mother-to-child transmission of HIV. Evidence-based Healthcare 2004;8:85-6. [DOI: 10.1016/j.ehbc.2004.02.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
236 Sarnquist CC, Cunningham SD, Sullivan B, Maldonado Y. The effectiveness of state and national policy on the implementation of perinatal HIV prevention interventions. Am J Public Health 2007;97:1041-6. [PMID: 17463383 DOI: 10.2105/AJPH.2005.072371] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
237 Grant RM. Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis. Clin Infect Dis 2010;50 Suppl 3:S96-101. [PMID: 20397962 DOI: 10.1086/651479] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
238 Rosenfield A, Figdor E. Where is the M in MTCT? The broader issues in mother-to-child transmission of HIV. Am J Public Health 2001;91:703-4. [PMID: 11344873 DOI: 10.2105/ajph.91.5.703] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
239 Cioffi CC, Seeley JR. Voluntary Pregnancy Screening at Syringe Exchanges: A Feasibility Study. J Prev Health Promot 2021;2:57-80. [PMID: 34693283 DOI: 10.1177/2632077020973362] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Crudeli CM, Aulicino PC, Rocco CA, Bologna R, Mangano A, Sen L. Relevance of early detection of HIV type 1 SI/CXCR4-using viruses in vertically infected children. AIDS Res Hum Retroviruses 2012;28:685-92. [PMID: 22023092 DOI: 10.1089/aid.2011.0111] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
241 Janes H, Donnell D, Gilbert PB, Brown ER, Nason M. Taking stock of the present and looking ahead: envisioning challenges in the design of future HIV prevention efficacy trials. Lancet HIV 2019;6:e475-82. [PMID: 31078451 DOI: 10.1016/S2352-3018(19)30133-X] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
242 Sharland M, Gibb DM, Tudor-Williams G. Advances in the prevention and treatment of paediatric HIV infection in the United Kingdom. Arch Dis Child 2002;87:178-80. [PMID: 12193420 DOI: 10.1136/adc.87.3.178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
243 Antonioiribarren J, Labarga P, Rubio R, Berenguer J, Miró J, Antela A, González J, Moreno S, Arrizabalaga J, Chamorro L, Clotet B, Gatell JM, López-aldeguer J, Martínez E, Polo R, Tuset M, Viciana P, Miguel Santamaría J, María Kindelán J, Ribera E, Segura F. Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el VIH (octubre 2004). Enfermedades Infecciosas y Microbiología Clínica 2004;22:564-642. [DOI: 10.1016/s0213-005x(04)73163-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
244 MacQueen KM, Auerbach JD. It is not just about "the trial": the critical role of effective engagement and participatory practices for moving the HIV research field forward. J Int AIDS Soc 2018;21 Suppl 7:e25179. [PMID: 30334608 DOI: 10.1002/jia2.25179] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
245 Gangakhedkar RR. Ending AIDS: The 90-90-90 strategy. Med J Armed Forces India 2017;73:3-4. [PMID: 28123237 DOI: 10.1016/j.mjafi.2016.12.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
246 Vermund SH. Modeling interventions to assess HIV epidemic impact in Africa. J Acquir Immune Defic Syndr 2011;58:121-4. [PMID: 21857360 DOI: 10.1097/QAI.0b013e31822ff904] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
247 Celum C, Baeten JM. Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence. Curr Opin Infect Dis 2012;25:51-7. [PMID: 22156901 DOI: 10.1097/QCO.0b013e32834ef5ef] [Cited by in Crossref: 116] [Cited by in F6Publishing: 72] [Article Influence: 11.6] [Reference Citation Analysis]
248 Vinot C, Gavard L, Tréluyer JM, Manceau S, Courbon E, Scherrmann JM, Declèves X, Duro D, Peytavin G, Mandelbrot L, Giraud C. Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression. Antimicrob Agents Chemother 2013;57:1415-20. [PMID: 23295922 DOI: 10.1128/AAC.01821-12] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
249 Smith SM. Pre-exposure chemoprophylaxis for HIV: it is time. Retrovirology 2004;1:16. [PMID: 15238164 DOI: 10.1186/1742-4690-1-16] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
250 Gogineni V, Schinazi RF, Hamann MT. Role of Marine Natural Products in the Genesis of Antiviral Agents. Chem Rev 2015;115:9655-706. [PMID: 26317854 DOI: 10.1021/cr4006318] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 6.9] [Reference Citation Analysis]
251 Cornu C, Kassai B, Fisch R, Chiron C, Alberti C, Guerrini R, Rosati A, Pons G, Tiddens H, Chabaud S, Caudri D, Ballot C, Kurbatova P, Castellan AC, Bajard A, Nony P, Aarons L, Bajard A, Ballot C, Bertrand Y, Bretz F, Caudri D, Castellan C, Chabaud S, Cornu C, Dufour F, Dunger-Baldauf C, Dupont JM, Fisch R, Guerrini R, Jullien V, Kassaï B, Nony P, Ogungbenro K, Pérol D, Pons G, Tiddens H, Rosati A, Alberti C, Chiron C, Kurbatova P, Nabbout R; CRESim & Epi-CRESim Project Groups. Experimental designs for small randomised clinical trials: an algorithm for choice. Orphanet J Rare Dis 2013;8:48. [PMID: 23531234 DOI: 10.1186/1750-1172-8-48] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
252 Puro V, Cicalini S, De Carli G, Soldani F, Antunes F, Balslev U, Begovac J, Bernasconi E, Boaventura JL, Martí MC, Civljak R, Evans B, Francioli P, Genasi F, Larsen C, Lot F, Lunding S, Marcus U, Pereira AA, Thomas T, Schonwald S, Ippolito G. Post-exposure prophylaxis of HIV infection in healthcare workers: recommendations for the European setting. Eur J Epidemiol 2004;19:577-84. [PMID: 15330131 DOI: 10.1023/b:ejep.0000032349.57057.8a] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
253 Kuhn L, Peterson I. Options for prevention of HIV transmission from mother to child, with a focus on developing countries. Paediatr Drugs 2002;4:191-203. [PMID: 11909011 DOI: 10.2165/00128072-200204030-00006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
254 Wedderburn CJ, Evans C, Yeung S, Gibb DM, Donald KA, Prendergast AJ. Growth and Neurodevelopment of HIV-Exposed Uninfected Children: a Conceptual Framework. Curr HIV/AIDS Rep 2019;16:501-13. [PMID: 31732866 DOI: 10.1007/s11904-019-00459-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
255 Kuhn L, Shiau S. The pharmacological treatment of acute HIV infections in neonates. Expert Rev Clin Pharmacol 2017;10:1353-61. [PMID: 29098898 DOI: 10.1080/17512433.2017.1398645] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
256 Knapp KM, Brogly SB, Muenz DG, Spiegel HM, Conway DH, Scott GB, Talbot JT, Shapiro DE, Read JS. Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals. Pediatr Infect Dis J 2012;31:164-70. [PMID: 21983213 DOI: 10.1097/INF.0b013e318235c7aa] [Cited by in Crossref: 49] [Cited by in F6Publishing: 19] [Article Influence: 4.9] [Reference Citation Analysis]
257 Bryson YJ, Mirochnick M, Stek A, Mofenson LM, Connor J, Capparelli E, Watts DH, Huang S, Hughes MD, Kaiser K, Purdue L, Asfaw Y, Keller M, Smith E; PACTG 353 Team. Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. HIV Clin Trials 2008;9:115-25. [PMID: 18474496 DOI: 10.1310/hct0902-115] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
258 Fowler MG, Flynn P, Aizire J. What is new in perinatal HIV prevention? Curr Opin Pediatr 2018;30:144-51. [PMID: 29315112 DOI: 10.1097/MOP.0000000000000579] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
259 Snowdin JW, Hsiung CH, Kesterson DG, Kamath VG, McKee EE. Effects of Zidovudine Treatment on Heart mRNA Expression and Mitochondrial DNA Copy Number Associated with Alterations in Deoxynucleoside Triphosphate Composition in a Neonatal Rat Model. Antimicrob Agents Chemother 2015;59:6328-36. [PMID: 26248377 DOI: 10.1128/AAC.01180-15] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
260 Ladner J, Besson MH, Rodrigues M, Sams K, Audureau E, Saba J. Prevention of mother-to-child HIV transmission in resource-limited settings: assessment of 99 Viramune Donation Programmes in 34 countries, 2000-2011. BMC Public Health 2013;13:470. [PMID: 23672811 DOI: 10.1186/1471-2458-13-470] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
261 Breckenridge A. Clinical pharmacology and therapeutics. BMJ 1995;310:377-80. [PMID: 7866217 DOI: 10.1136/bmj.310.6976.377] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
262 Yeh RF, Rezk NL, Kashuba AD, Dumond JB, Tappouni HL, Tien HC, Chen YC, Vourvahis M, Horton AL, Fiscus SA, Patterson KB. Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women. Antimicrob Agents Chemother 2009;53:2367-74. [PMID: 19307360 DOI: 10.1128/AAC.01523-08] [Cited by in Crossref: 43] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
263 Trepka MJ, Mukherjee S, Beck-Sagué C, Maddox LM, Fennie KP, Sheehan DM, Prabhakar M, Thompson D, Lieb S. Missed Opportunities for Preventing Perinatal Transmission of Human Immunodeficiency Virus, Florida, 2007-2014. South Med J 2017;110:116-28. [PMID: 28158882 DOI: 10.14423/SMJ.0000000000000609] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
264 Wei L, Mansoor N, Khan RA, Czejka M, Ahmad T, Ahmed M, Ali M, Yang DH. WB-PBPK approach in predicting zidovudine pharmacokinetics in preterm neonates. Biopharm Drug Dispos 2019;40:341-9. [PMID: 31693190 DOI: 10.1002/bdd.2208] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
265 Chin H, Chern BSM. Pregnancy Outcomes in HIV-Positive Women in Singapore. Proceedings of Singapore Healthcare 2014;23:38-41. [DOI: 10.1177/201010581402300107] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
266 Thorpe AS. Doing the Right Thing or Doing the Thing Right: Implications of Participant Withdrawal. Organizational Research Methods 2014;17:255-77. [DOI: 10.1177/1094428114524828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
267 Cescon A, Patterson S, Davey C, Ding E, Raboud JM, Chan K, Loutfy MR, Cooper C, Burchell AN, Palmer AK, Tsoukas C, Machouf N, Klein MB, Rourke SB, Rachlis A, Hogg RS, Montaner JS; CANOC Collaboration. Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care. J Int AIDS Soc 2015;18:20024. [PMID: 26443752 DOI: 10.7448/IAS.18.1.20024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
268 Dimian C, Bingham J. Sexually transmitted diseases and pregnancy. J Eur Acad Dermatol Venerol 1996;6:1-10. [DOI: 10.1111/j.1468-3083.1996.tb00125.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
269 Flash C, Krakower D, Mayer KH. The Promise of Antiretrovirals for HIV Prevention. Curr Infect Dis Rep 2012;14:185-93. [PMID: 22351302 DOI: 10.1007/s11908-012-0242-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
270 Gayle HD, Hill GL. Global impact of human immunodeficiency virus and AIDS. Clin Microbiol Rev 2001;14:327-35. [PMID: 11292641 DOI: 10.1128/CMR.14.2.327-335.2001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
271 Biswas A. Generalized Delayed Response in Randomized Play-the-Winner Rule. Communications in Statistics - Simulation and Computation 2003;32:259-74. [DOI: 10.1081/sac-120013125] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
272 . Morbidity and mortality weekly report. The American Journal of Medicine 1997;102:4-8. [DOI: 10.1016/s0002-9343(97)89440-5] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
273 Kuonza LR, Tshuma CD, Shambira GN, Tshimanga M. Non-adherence to the single dose nevirapine regimen for the prevention of mother-to-child transmission of HIV in Bindura town, Zimbabwe: a cross-sectional analytic study. BMC Public Health 2010;10:218. [PMID: 20426830 DOI: 10.1186/1471-2458-10-218] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
274 Kim JU, Oleribe O, Njie R, Taylor-Robinson SD. A time for new north-south relationships in global health. Int J Gen Med 2017;10:401-8. [PMID: 29158688 DOI: 10.2147/IJGM.S146475] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
275 Purohit V, Rapaka RS, Shurtleff D. Mother-to-child transmission (MTCT) of HIV and drugs of abuse in post-highly active antiretroviral therapy (HAART) era. J Neuroimmune Pharmacol 2010;5:507-15. [PMID: 20838913 DOI: 10.1007/s11481-010-9242-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
276 Forsyth BW. The AIDS Epidemic: Past and Future. Child and Adolescent Psychiatric Clinics of North America 2000;9:267-78. [DOI: 10.1016/s1056-4993(18)30118-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
277 Hanley S, Ross A. An exploration of anaemia in low-birthweight infants exposed to perinatal zidovudine at the neonatal unit at a regional hospital in Durban. South African Family Practice 2015;56:276-80. [DOI: 10.1080/20786190.2014.975472] [Reference Citation Analysis]
278 Cardonick E, Daly S, Dooley M, Elles K, Silverman NS. Determinants of antepartum human immunodeficiency virus testing in a non-Medicaid obstetric population. Infect Dis Obstet Gynecol 1998;6:209-13. [PMID: 9894175 DOI: 10.1002/(SICI)1098-0997(1998)6:5<209::AID-IDOG4>3.0.CO;2-J] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
279 Janssen RS, Holtgrave DR, Valdiserri RO, Shepherd M, Gayle HD, De Cock KM. The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals. Am J Public Health 2001;91:1019-24. [PMID: 11441723 DOI: 10.2105/ajph.91.7.1019] [Cited by in Crossref: 308] [Cited by in F6Publishing: 95] [Article Influence: 14.7] [Reference Citation Analysis]
280 Fleming TR, DeGruttola V, Donnell D. Designing & Conducting Trials To Reliably Evaluate HIV Prevention Interventions. Stat Commun Infect Dis 2019;11:20190001. [PMID: 33777327 DOI: 10.1515/scid-2019-0001] [Reference Citation Analysis]
281 Kamara P, Melendez-Guerrero L, Arroyo M, Weiss H, Jolly P. Maternal plasma viral load and neutralizing/enhancing antibodies in vertical transmission of HIV: a non-randomized prospective study. Virol J 2005;2:15. [PMID: 15730556 DOI: 10.1186/1743-422X-2-15] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
282 Vreeman RC, Scanlon ML, McHenry MS, Nyandiko WM. The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children. J Int AIDS Soc 2015;18:20258. [PMID: 26639114 DOI: 10.7448/IAS.18.7.20258] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
283 Katz IT, Leister E, Kacanek D, Hughes MD, Bardeguez A, Livingston E, Stek A, Shapiro DE, Tuomala R. Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study. Ann Intern Med 2015;162:90-9. [PMID: 25599347 DOI: 10.7326/M13-2005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 4.1] [Reference Citation Analysis]
284 Schüklenk U, Philpott S. AIDS – the time for changes in law and policy is now. International Journal of Law in Context 2011;7:305-17. [DOI: 10.1017/s1744552311000140] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
285 Beck EJ, Mandalia S, Griffith R, Beecham J, Walters MD, Boulton M, Miller DL. Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre. Pharmacoeconomics 2000;17:53-69. [PMID: 10747765 DOI: 10.2165/00019053-200017010-00004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
286 . Care of the infant born to an HIV-positive mother. Paediatr Child Health 2000;5:161-70. [PMID: 20177515 DOI: 10.1093/pch/5.3.161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
287 Collins JA, Thompson MG, Paintsil E, Ricketts M, Gedzior J, Alexander L. Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants. J Virol 2004;78:603-11. [PMID: 14694092 DOI: 10.1128/jvi.78.2.603-611.2004] [Cited by in Crossref: 74] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
288 McKinney RE Jr. Use of antiretroviral therapy in children and pregnant women. Adv Exp Med Biol 1996;394:345-54. [PMID: 8815700 DOI: 10.1007/978-1-4757-9209-6_32] [Reference Citation Analysis]
289 Scheid DC, Hamm RM, Stevens KW. Cost effectiveness of human immunodeficiency virus postexposure prophylaxis for healthcare workers. Pharmacoeconomics 2000;18:355-68. [PMID: 15344304 DOI: 10.2165/00019053-200018040-00004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
290 Wild V. Plädoyer für einen Einschluss schwangerer Frauen in Arzneimittelstudien*. Ethik Med 2007;19:7-23. [DOI: 10.1007/s00481-007-0494-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
291 Rollins N, Mahy M, Becquet R, Kuhn L, Creek T, Mofenson L. Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models. Sex Transm Infect 2012;88 Suppl 2:i44-51. [PMID: 23172345 DOI: 10.1136/sextrans-2012-050709] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
292 Tandon R, SenGupta D, Ndhlovu LC, Vieira RG, Jones RB, York VA, Vieira VA, Sharp ER, Wiznia AA, Ostrowski MA, Rosenberg MG, Nixon DF. Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects. J Virol 2011;85:11526-31. [PMID: 21880743 DOI: 10.1128/JVI.05418-11] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
293 Van Rompay KK, Otsyula MG, Marthas ML, Miller CJ, McChesney MB, Pedersen NC. Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS. Antimicrob Agents Chemother 1995;39:125-31. [PMID: 7695293 DOI: 10.1128/AAC.39.1.125] [Cited by in Crossref: 66] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
294 Cribiù FM, Erra R, Pugni L, Rubio-Perez C, Alonso L, Simonetti S, Croci GA, Serna G, Ronchi A, Pietrasanta C, Lunghi G, Fagnani AM, Piñana M, Matter M, Tzankov A, Terracciano L, Anton A, Ferrazzi E, Ferrero S, Iurlaro E, Seoane J, Nuciforo P. Severe SARS-CoV-2 placenta infection can impact neonatal outcome in the absence of vertical transmission. J Clin Invest 2021;131:145427. [PMID: 33497369 DOI: 10.1172/JCI145427] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
295 Zorrilla CD, Tamayo-Agrait V. Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy. HIV AIDS (Auckl) 2009;1:41-53. [PMID: 22096378 DOI: 10.2147/hiv.s6326] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
296 Quintino MP, Nakamura MU, Simões Mde J, Araujo Júnior E, Filho RM, Torloni MR, Espiridião S, Kulay Júnior L. Chronic use of indinavir in albino rat pregnancy (Rattus norvegicus albinus, Rodentia, Mammalia): biological assay. J Obstet Gynaecol Res 2011;37:1212-5. [PMID: 21518132 DOI: 10.1111/j.1447-0756.2010.01504.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
297 Ziske J, Kunz A, Sewangi J, Lau I, Dugange F, Hauser A, Kirschner W, Harms G, Theuring S. Hematological changes in women and infants exposed to an AZT-containing regimen for prevention of mother-to-child-transmission of HIV in Tanzania. PLoS One 2013;8:e55633. [PMID: 23405185 DOI: 10.1371/journal.pone.0055633] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
298 Dinsmoor MJ, Forrest ST. Lack of an effect of protease inhibitor use on glucose tolerance during pregnancy. Infect Dis Obstet Gynecol 2002;10:187-91. [PMID: 12648312 DOI: 10.1155/S1064744902000212] [Cited by in Crossref: 11] [Article Influence: 0.6] [Reference Citation Analysis]
299 Annas GJ, Grodin MA. Human rights and maternal-fetal HIV transmission prevention trials in Africa. Am J Public Health 1998;88:560-3. [PMID: 9550993 DOI: 10.2105/ajph.88.4.560] [Cited by in Crossref: 64] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
300 Sirois PA, Huo Y, Williams PL, Malee K, Garvie PA, Kammerer B, Rich K, Van Dyke RB, Nozyce ML; Pediatric HIVAIDS Cohort Study. Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants. Pediatr Infect Dis J 2013;32:648-55. [PMID: 23340561 DOI: 10.1097/INF.0b013e318284129a] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
301 El-Shabrawi MHF, Kamal NM, Mogahed EA, Elhusseini MA, Aljabri MF. Perinatal transmission of hepatitis C virus: an update. Arch Med Sci 2020;16:1360-9. [PMID: 33224335 DOI: 10.5114/aoms.2019.83644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
302 Nuttall JJC. Antiretroviral therapy during the neonatal period. South Afr J HIV Med 2015;16:361. [PMID: 29568586 DOI: 10.4102/sajhivmed.v16i1.361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
303 Zaric GS, Bayoumi AM, Brandeau ML, Owens DK. The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with men. Med Decis Making 2008;28:359-76. [PMID: 18349433 DOI: 10.1177/0272989X07312714] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
304 Millum J, Grady C. The ethics of placebo-controlled trials: methodological justifications. Contemp Clin Trials 2013;36:510-4. [PMID: 24035802 DOI: 10.1016/j.cct.2013.09.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
305 Ogbuagu O, Bruce RD. Reaching the unreached: treatment as prevention as a workable strategy to mitigate HIV and its consequences in high-risk groups. Curr HIV/AIDS Rep 2014;11:505-12. [PMID: 25342571 DOI: 10.1007/s11904-014-0238-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
306 Lalani T, Hicks C. Does antiretroviral therapy prevent HIV transmission to sexual partners? Curr HIV/AIDS Rep 2007;4:80-5. [PMID: 17547829 DOI: 10.1007/s11904-007-0012-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
307 Delicio AM, Lajos GJ, Amaral E, Cavichiolli F, Polydoro M, Milanez H. Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study. Reprod Health 2018;15:76. [PMID: 29747664 DOI: 10.1186/s12978-018-0513-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
308 Boer K, England K, Godfried MH, Thorne C; European Collaborative Study. Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe. HIV Med 2010;11:368-78. [PMID: 20059573 DOI: 10.1111/j.1468-1293.2009.00800.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 0.2] [Reference Citation Analysis]
309 Lindsey JC, Shah SK, Siberry GK, Jean-Philippe P, Levin MJ. Ethical tradeoffs in trial design: case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings. Dev World Bioeth 2013;13:95-104. [PMID: 23725055 DOI: 10.1111/dewb.12028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
310 Beima-Sofie KM, Trinidad SB, Ngure K, Heffron R, Baeten JM, John-Stewart GC, Kelley M. Lessons from PrEP: A Qualitative Study Investigating How Clinical and Policy Experts Weigh Ethics and Evidence When Evaluating Preventive Medications for Use in Pregnant and Breastfeeding Women. AIDS Behav 2019;23:1858-70. [PMID: 30552519 DOI: 10.1007/s10461-018-2361-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
311 Lundgren JD, Babiker AG, Gordin FM, Borges ÁH, Neaton JD. When to start antiretroviral therapy: the need for an evidence base during early HIV infection. BMC Med 2013;11:148. [PMID: 23767777 DOI: 10.1186/1741-7015-11-148] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
312 Hicks LK, Laupacis A, Slutsky AS. A primer on data safety monitoring boards: mission, methods, and controversies. Intensive Care Med 2007;33:1815-8. [PMID: 17661013 DOI: 10.1007/s00134-007-0794-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
313 Abdool Karim SS. Placebo controls in HIV perinatal transmission trials: a South African's viewpoint. Am J Public Health 1998;88:564-6. [PMID: 9550994 DOI: 10.2105/ajph.88.4.564] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
314 Flynn PM, Mirochnick M, Shapiro DE, Bardeguez A, Rodman J, Robbins B, Huang S, Fiscus SA, Van Rompay KK, Rooney JF, Kearney B, Mofenson LM, Watts DH, Jean-Philippe P, Heckman B, Thorpe E Jr, Cotter A, Purswani M; PACTG 394 Study Team. Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants. Antimicrob Agents Chemother 2011;55:5914-22. [PMID: 21896911 DOI: 10.1128/AAC.00544-11] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
315 Pikora CA, Sullivan JL, Panicali D, Luzuriaga K. Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants. J Exp Med 1997;185:1153-61. [PMID: 9104802 DOI: 10.1084/jem.185.7.1153] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 1.9] [Reference Citation Analysis]
316 Deville J, Bryson Y. Perinatal Transmission of HIV: Recognition and Treatment Interventions. Curr Infect Dis Rep 2001;3:388-96. [PMID: 11470031 DOI: 10.1007/s11908-001-0080-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
317 Joffe S, Miller FG. Ethics of cancer clinical trials in low-resource settings. J Clin Oncol 2014;32:3192-6. [PMID: 25185082 DOI: 10.1200/JCO.2014.56.9780] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
318 Cervia JS. Easing the transition of HIV-infected adolescents to adult care. AIDS Patient Care STDS. 2013;27:692-696. [PMID: 24073595 DOI: 10.1089/apc.2013.0253] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
319 Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587-99. [PMID: 21091279 DOI: 10.1056/NEJMoa1011205] [Cited by in Crossref: 3101] [Cited by in F6Publishing: 1929] [Article Influence: 258.4] [Reference Citation Analysis]
320 Bennett R. Antenatal genetic testing and the right to remain in ignorance. Theor Med Bioeth 2001;22:461-71. [PMID: 11808680 DOI: 10.1023/a:1013015019369] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
321 Mirochnick M, Clarke DF, Dorenbaum A. Nevirapine: pharmacokinetic considerations in children and pregnant women. Clin Pharmacokinet 2000;39:281-93. [PMID: 11069214 DOI: 10.2165/00003088-200039040-00004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
322 van Rompay KK, Dailey PJ, Tarara RP, Canfield DR, Aguirre NL, Cherrington JM, Lamy PD, Bischofberger N, Pedersen NC, Marthas ML. Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn Rhesus macaques. J Virol 1999;73:2947-55. [PMID: 10074144 DOI: 10.1128/JVI.73.4.2947-2955.1999] [Cited by in Crossref: 53] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
323 Nduati R, Richardson BA, John G, Mbori-Ngacha D, Mwatha A, Ndinya-Achola J, Bwayo J, Onyango FE, Kreiss J. Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial. Lancet 2001;357:1651-5. [PMID: 11425369 DOI: 10.1016/S0140-6736(00)04820-0] [Cited by in Crossref: 141] [Cited by in F6Publishing: 32] [Article Influence: 6.7] [Reference Citation Analysis]
324 Nguyen TA, Oosterhoff P, Ngoc YP, Wright P, Hardon A. Barriers to access prevention of mother-to-child transmission for HIV positive women in a well-resourced setting in Vietnam. AIDS Res Ther 2008;5:7. [PMID: 18419808 DOI: 10.1186/1742-6405-5-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
325 John-Stewart G. eHealth and Prevention of Mother-to-Child Transmission of HIV. Curr HIV/AIDS Rep 2018;15:350-7. [PMID: 29931467 DOI: 10.1007/s11904-018-0408-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
326 Unadkat JD, Wara DW, Hughes MD, Mathias AA, Holland DT, Paul ME, Connor J, Huang S, Nguyen BY, Watts DH, Mofenson LM, Smith E, Deutsch P, Kaiser KA, Tuomala RE. Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother 2007;51:783-6. [PMID: 17158945 DOI: 10.1128/AAC.00420-06] [Cited by in Crossref: 63] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
327 Caniglia EC, Patel K, Huo Y, Williams PL, Kapetanovic S, Rich KC, Sirois PA, Jacobson DL, Hernandez-Diaz S, Hernán MA, Seage GR 3rd; Pediatric HIVAIDS Cohort Study. Atazanavir exposure in utero and neurodevelopment in infants: a comparative safety study. AIDS 2016;30:1267-78. [PMID: 26867136 DOI: 10.1097/QAD.0000000000001052] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
328 Machado ES, Hofer CB, Costa TT, Nogueira SA, Oliveira RH, Abreu TF, Evangelista LA, Farias IF, Mercadante RT, Garcia MF, Neves RC, Costa VM, Lambert JS. Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception. Sex Transm Infect 2009;85:82-7. [PMID: 18987014 DOI: 10.1136/sti.2008.032300] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 5.1] [Reference Citation Analysis]
329 Ciaranello AL, Myer L, Kelly K, Christensen S, Daskilewicz K, Doherty K, Bekker LG, Hou T, Wood R, Francke JA, Wools-Kaloustian K, Freedberg KA, Walensky RP. Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis. PLoS One 2015;10:e0117751. [PMID: 25756498 DOI: 10.1371/journal.pone.0117751] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
330 Floridia M, Ravizza M, Tamburrini E, Anzidei G, Tibaldi C, Maccabruni A, Guaraldi G, Alberico S, Vimercati A, Degli Antoni A, Ferrazzi E; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy. Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy. Epidemiol Infect 2006;134:1120-7. [PMID: 16512968 DOI: 10.1017/S0950268806006066] [Cited by in Crossref: 35] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
331 Bae WH, Wester C, Smeaton LM, Shapiro RL, Lockman S, Onyait K, Thior I, Essex M. Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants. AIDS 2008;22:1633-40. [PMID: 18670224 DOI: 10.1097/QAD.0b013e328307a029] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
332 Machado ES, Krauss MR, Megazzini K, Coutinho CM, Kreitchmann R, Melo VH, Pilotto JH, Ceriotto M, Hofer CB, Siberry GK, Watts DH; NICHD International Site Development Initiative (NISDI) Pediatric Protocol. Hypertension, preeclampsia and eclampsia among HIV-infected pregnant women from Latin America and Caribbean countries. J Infect 2014;68:572-80. [PMID: 24462561 DOI: 10.1016/j.jinf.2013.12.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
333 Chrystie IL, Wolfe CD, Kennedy J, Zander L, Tilzey A, Banatvala JE. Voluntary, named testing for HIV in a community based antenatal clinic: a pilot study. BMJ 1995;311:928-31. [PMID: 7580555 DOI: 10.1136/bmj.311.7010.928] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
334 Strauss RP, Sengupta S, Quinn SC, Goeppinger J, Spaulding C, Kegeles SM, Millett G. The role of community advisory boards: involving communities in the informed consent process. Am J Public Health 2001;91:1938-43. [PMID: 11726369 DOI: 10.2105/ajph.91.12.1938] [Cited by in Crossref: 125] [Cited by in F6Publishing: 62] [Article Influence: 6.0] [Reference Citation Analysis]
335 Rahimian A, Driscoll M, Taylor D. The maternal and child health sites' practices regarding HIV education, counseling, and testing of women of reproductive age in Chicago: barriers to universal implementation. Matern Child Health J 1998;2:35-44. [PMID: 10728257 DOI: 10.1023/a:1021893525536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
336 Spence JM. Should emergency departments offer postexposure prophylaxis for non-occupational exposure to HIV? CJEM 2003;5:38-45. [PMID: 17659152 DOI: 10.1017/s1481803500008101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
337 Tadesse BT, Kinloch NN, Baraki B, Lapointe HR, Cobarrubias KD, Brockman MA, Brumme CJ, Foster BA, Jerene D, Makonnen E, Aklillu E, Brumme ZL. High Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia. Viruses 2018;10:E60. [PMID: 29389912 DOI: 10.3390/v10020060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
338 Neubert J, Pfeffer M, Borkhardt A, Niehues T, Adams O, Bolten M, Reuter S, Stannigel H, Laws HJ. Risk adapted transmission prophylaxis to prevent vertical HIV-1 transmission: effectiveness and safety of an abbreviated regimen of postnatal oral zidovudine. BMC Pregnancy Childbirth 2013;13:22. [PMID: 23347580 DOI: 10.1186/1471-2393-13-22] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
339 Bayer A, Delorme-Axford E, Sleigher C, Frey TK, Trobaugh DW, Klimstra WB, Emert-Sedlak LA, Smithgall TE, Kinchington PR, Vadia S, Seveau S, Boyle JP, Coyne CB, Sadovsky Y. Human trophoblasts confer resistance to viruses implicated in perinatal infection. Am J Obstet Gynecol 2015;212:71.e1-8. [PMID: 25108145 DOI: 10.1016/j.ajog.2014.07.060] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 7.4] [Reference Citation Analysis]
340 Sharland M, Gibb D, Tudor-Williams G, Walters S, Novelli V. Paediatric HIV infection. Arch Dis Child 1997;76:293-6. [PMID: 9166017 DOI: 10.1136/adc.76.4.293] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
341 Barré-Sinoussi F, Ross AL, Delfraissy JF. Past, present and future: 30 years of HIV research. Nat Rev Microbiol 2013;11:877-83. [PMID: 24162027 DOI: 10.1038/nrmicro3132] [Cited by in Crossref: 156] [Cited by in F6Publishing: 142] [Article Influence: 17.3] [Reference Citation Analysis]
342 Eary RL, Borders AE, Handler A, Cohen MH, Garcia PM. AZT Availability in Illinois birthing hospitals: is the perinatal HIV prevention safety net in place? Matern Child Health J 2007;11:313-8. [PMID: 17243021 DOI: 10.1007/s10995-006-0175-y] [Reference Citation Analysis]
343 Sharland M, Gibb DM, Tudor-Williams G. Advances in the prevention and treatment of paediatric HIV infection in the United Kingdom. Sex Transm Infect 2003;79:53-5. [PMID: 12576615 DOI: 10.1136/sti.79.1.53] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
344 Tabone MD, Vaudre G, Dehée A, Dollfus C. [HIV mother to child transmission: improvement and future]. Arch Pediatr 2005;12:1-3. [PMID: 15653046 DOI: 10.1016/j.arcped.2004.11.007] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
345 Ladner J, Besson MH, Rodrigues M, Saba J, Audureau E. Performance of HIV Prevention of Mother-To-Child Transmission Programs in Sub-Saharan Africa: Longitudinal Assessment of 64 Nevirapine-Based Programs Implemented in 25 Countries, 2000-2011. PLoS One 2015;10:e0130103. [PMID: 26098311 DOI: 10.1371/journal.pone.0130103] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
346 Beltrami EM, Williams IT, Shapiro CN, Chamberland ME. Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev. 2000;13:385-407. [PMID: 10885983 DOI: 10.1128/cmr.13.3.385-407.2000] [Cited by in Crossref: 175] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
347 Mbori-Ngacha D, Richardson BA, Overbaugh J, Panteleeff DD, Nduati R, Steele M, John-Stewart G. Short-term effect of zidovudine on plasma and genital human immunodeficiency virus type 1 and viral turnover in these compartments. J Virol 2003;77:7702-5. [PMID: 12805473 DOI: 10.1128/jvi.77.13.7702-7705.2003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
348 Amin O, Powers J, Bricker KM, Chahroudi A. Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure. Front Immunol 2021;12:757400. [PMID: 34745130 DOI: 10.3389/fimmu.2021.757400] [Reference Citation Analysis]
349 Schuster MA, Kanouse DE, Morton SC, Bozzette SA, Miu A, Scott GB, Shapiro MF. HIV-infected parents and their children in the United States. Am J Public Health 2000;90:1074-81. [PMID: 10897185 DOI: 10.2105/ajph.90.7.1074] [Cited by in Crossref: 83] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
350 Zhang H, Dornadula G, Wu Y, Havlir D, Richman DD, Pomerantz RJ. Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivo. J Virol 1996;70:628-34. [PMID: 8523584 DOI: 10.1128/JVI.70.1.628-634.1996] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
351 Moreno Pérez D, García Martín FJ, Vázquez López R, Jurado Ortiz A. [Unexpected perinatal HIV-1 infection]. An Pediatr (Barc) 2005;62:598-9. [PMID: 15927134 DOI: 10.1157/13075561] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
352 Abramson JS. Society for Pediatric Research presidential address 1996: Star Wars empiricism--will the empire (SPR) strike back? Pediatr Res 1996;40:784-9. [PMID: 8947951 DOI: 10.1203/00006450-199612000-00002] [Reference Citation Analysis]
353 Paintsil E. Monitoring Antiretroviral Therapy in HIV-Infected Children in Resource-Limited Countries: A Tale of Two Epidemics. AIDS Res Treat 2011;2011:280901. [PMID: 21490777 DOI: 10.1155/2011/280901] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
354 Wendler D, Emanuel EJ, Lie RK. The standard of care debate: can research in developing countries be both ethical and responsive to those countries' health needs? Am J Public Health 2004;94:923-8. [PMID: 15249290 DOI: 10.2105/ajph.94.6.923] [Cited by in Crossref: 60] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
355 Rongkavilit C, Asmar BI. Advances in prevention of mother-to-child HIV transmission. Indian J Pediatr 2004;71:69-79. [PMID: 14979391 DOI: 10.1007/BF02725662] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
356 Teixeira LB, Pilecco FB, Vigo Á, Drachler ML, Leite JC, Knauth DR. Factors associated with post-diagnosis pregnancies in women living with HIV in the south of Brazil. PLoS One 2017;12:e0172514. [PMID: 28222175 DOI: 10.1371/journal.pone.0172514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
357 Steer P. Recent advances. Obstetrics. BMJ 1995;311:1209-12. [PMID: 7488904 DOI: 10.1136/bmj.311.7014.1209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
358 McIntyre J, Gray G. What can we do to reduce mother to child transmission of HIV? BMJ 2002;324:218-21. [PMID: 11809646 DOI: 10.1136/bmj.324.7331.218] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
359 Bompart F, Hirsch F, Bertoye P, Vray M, Bazin B, Chambon J, de Rochegonde T, Deloron P, Garenne M, Gersberg M, Guérin P, Juillet Y, Lameyre V, Leblond A, L’hadj M, Ravinetto R, Riveau G, Schacht A, Simon F, Toneatti C, Torreele E, Urfalino P. Good Clinical Practice in Developing Countries: Applying Recommendations. Therapies 2008;63:83-8. [DOI: 10.2515/therapie:2008023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
360 Williams PL, Huo Y, Rutstein R, Hazra R, Rough K, Van Dyke RB, Chadwick EG. Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015. AIDS Patient Care STDS 2018;32:48-57. [PMID: 30346801 DOI: 10.1089/apc.2017.0295] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
361 Ellenberg SS, Morris JS. AIDS and COVID: A tale of two pandemics and the role of statisticians. Stat Med 2021;40:2499-510. [PMID: 33963579 DOI: 10.1002/sim.8936] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
362 Mayer KH, Venkatesh KK. Chemoprophylaxis for HIV prevention: new opportunities and new questions. J Acquir Immune Defic Syndr 2010;55 Suppl 2:S122-7. [PMID: 21406981 DOI: 10.1097/QAI.0b013e3181fbcb4c] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
363 Lemberg DA, Palasanthiran P, Goode M, Ziegler JB. Tolerabilities of antiretrovirals in paediatric HIV infection. Drug Saf 2002;25:973-91. [PMID: 12408730 DOI: 10.2165/00002018-200225140-00001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
364 Schnoll JG, Temsamrit B, Zhang D, Song H, Ming GL, Christian KM. Evaluating Neurodevelopmental Consequences of Perinatal Exposure to Antiretroviral Drugs: Current Challenges and New Approaches. J Neuroimmune Pharmacol 2021;16:113-29. [PMID: 31512167 DOI: 10.1007/s11481-019-09880-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
365 England K, Thorne C; European Collaborative Study. Use of neonatal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV is decreasing in Western Europe. Clin Infect Dis 2009;48:1797-800. [PMID: 19473091 DOI: 10.1086/599230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
366 Thompson CG, Cohen MS, Kashuba AD. Antiretroviral pharmacology in mucosal tissues. J Acquir Immune Defic Syndr 2013;63 Suppl 2:S240-7. [PMID: 23764642 DOI: 10.1097/QAI.0b013e3182986ff8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
367 van 't Klooster G, Hoeben E, Borghys H, Looszova A, Bouche MP, van Velsen F, Baert L. Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation. Antimicrob Agents Chemother 2010;54:2042-50. [PMID: 20160045 DOI: 10.1128/AAC.01529-09] [Cited by in Crossref: 137] [Cited by in F6Publishing: 59] [Article Influence: 11.4] [Reference Citation Analysis]
368 Kroon M. Recognising and managing increased HIV transmission risk in newborns. South Afr J HIV Med 2015;16:371. [PMID: 29568591 DOI: 10.4102/sajhivmed.v16i1.371] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
369 MacDonagh SE, Masters J, Helps BA, Tookey PA, Ades AE, Gibb DM. Descriptive survey of antenatal HIV testing in London: policy, uptake, and detection. BMJ 1996;313:532-3. [PMID: 8789982 DOI: 10.1136/bmj.313.7056.532] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
370 St John MA, Denny F, Babb D. Outcome of HIV-infected Pregnant Women and Their Offspring in Barbados: A Five-year Study. West Indian Med J 2015;64:49-53. [PMID: 26035816 DOI: 10.7727/wimj.2015.109] [Reference Citation Analysis]
371 Behbahani H, Popek E, Garcia P, Andersson J, Spetz AL, Landay A, Flener Z, Patterson BK. Up-regulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission. Am J Pathol 2000;157:1811-8. [PMID: 11106553 DOI: 10.1016/S0002-9440(10)64819-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
372 Santini-Oliveira M, Estrela Rde C, Veloso VG, Cattani VB, Yanavich C, Velasque L, Torres TS, Marins LM, Pilotto JH, João EC, Gonçalves JC, Grinsztejn B. Randomized clinical trial comparing the pharmacokinetics of standard- and increased-dosage lopinavir-ritonavir coformulation tablets in HIV-positive pregnant women. Antimicrob Agents Chemother 2014;58:2884-93. [PMID: 24614377 DOI: 10.1128/AAC.02599-13] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
373 Mahajan M. Rethinking prevention: Shifting conceptualizations of evidence and intervention in South Africa’s AIDS epidemic. BioSocieties 2018;13:148-69. [DOI: 10.1057/s41292-017-0062-3] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
374 Kim LH, Cohan DL, Sparks TN, Pilliod RA, Arinaitwe E, Caughey AB. The cost-effectiveness of repeat HIV testing during pregnancy in a resource-limited setting. J Acquir Immune Defic Syndr 2013;63:195-200. [PMID: 23392461 DOI: 10.1097/QAI.0b013e3182895565] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
375 Taylor GP, Lyall EG, Mercey D, Smith R, Chester T, Newell ML, Tudor-Williams G. British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy (1998). Sex Transm Infect 1999;75:90-7. [PMID: 10448360 DOI: 10.1136/sti.75.2.90] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
376 Jackson LW, Lee NL, Samet JM. Frequency of policy recommendations in epidemiologic publications. Am J Public Health 1999;89:1206-11. [PMID: 10432907 DOI: 10.2105/ajph.89.8.1206] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
377 Dorman RM, Yee LM, Sutton SH. Pill aversion in HIV-infected pregnant women: Theory to practice. J Perinatol 2017;37:215-9. [PMID: 27735932 DOI: 10.1038/jp.2016.176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
378 Pau AK, George JM. Antiretroviral therapy: current drugs. Infect Dis Clin North Am 2014;28:371-402. [PMID: 25151562 DOI: 10.1016/j.idc.2014.06.001] [Cited by in Crossref: 88] [Cited by in F6Publishing: 77] [Article Influence: 12.6] [Reference Citation Analysis]
379 Garland SM, O'Reilly MA. The risks and benefits of antimicrobial therapy in pregnancy. Drug Saf 1995;13:188-205. [PMID: 7495503 DOI: 10.2165/00002018-199513030-00004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
380 Fink MJ, Goodman A, Hight E, Miller-mack E, De Groot A. Critical Prevention, Critical Care: Gynecological and Obstetrical Aspects of Comprehensive HIV Prevention and Treatment Among Incarcerated Women. Journal of Correctional Health Care 1998;5:201-23. [DOI: 10.1177/107834589800500206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
381 Dickover RE, Garratty EM, Plaeger S, Bryson YJ. Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. J Virol 2001;75:2194-203. [PMID: 11160723 DOI: 10.1128/JVI.75.5.2194-2203.2001] [Cited by in Crossref: 76] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
382 Robinson PG, Challacombe SJ, Sheiham A. Oral examination: a screening tool for HIV infection? Sex Transm Infect 1998;74:345-8. [PMID: 10195030 DOI: 10.1136/sti.74.5.345] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
383 Xu J, Yin G. Two-stage adaptive randomization for delayed response in clinical trials. J R Stat Soc C 2014;63:559-78. [DOI: 10.1111/rssc.12048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
384 Ejigu Y, Magnus JH, Sundby J, Magnus MC. Pregnancy outcome among HIV-infected women on different antiretroviral therapies in Ethiopia: a cohort study. BMJ Open 2019;9:e027344. [PMID: 31383698 DOI: 10.1136/bmjopen-2018-027344] [Reference Citation Analysis]
385 Ibeziako NS, Ubesie AC, Emodi IJ, Ayuk AC, Iloh KK, Ikefuna AN. Mother-to-child transmission of HIV: the pre-rapid advice experience of the university of Nigeria teaching hospital Ituku/Ozalla, Enugu, South-east Nigeria. BMC Res Notes 2012;5:305. [PMID: 22713282 DOI: 10.1186/1756-0500-5-305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
386 Areechokchai D, Bowonwatanuwong C, Phonrat B, Pitisuttithum P, Maek-A-Nantawat W. Pregnancy outcomes among HIV-infected women undergoing antiretroviral therapy. Open AIDS J 2009;3:8-13. [PMID: 19543534 DOI: 10.2174/1874613600903010008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
387 Hoehn RS, Abbott DE. Beyond the bedside: A review of translational medicine in global health. World J Transl Med 2015; 4(1): 1-10 [DOI: 10.5528/wjtm.v4.i1.1] [Reference Citation Analysis]
388 Montano M, Rarick M, Sebastiani P, Brinkmann P, Russell M, Navis A, Wester C, Thior I, Essex M. Gene-expression profiling of HIV-1 infection and perinatal transmission in Botswana. Genes Immun 2006;7:298-309. [PMID: 16691187 DOI: 10.1038/sj.gene.6364297] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
389 Sturt AS, Halpern MS, Sullivan B, Maldonado YA. Timing of antiretroviral therapy initiation and its impact on disease progression in perinatal human immunodeficiency virus-1 infection. Pediatr Infect Dis J 2012;31:53-60. [PMID: 21979798 DOI: 10.1097/INF.0b013e31823515a2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
390 Kordy F, Al-Hajjar S, Frayha HH, Al-Khlaif R, Al-Shahrani D, Akthar J. Human immunodeficiency virus infection in Saudi Arabian children: transmission, clinical manifestations and outcome. Ann Saudi Med 2006;26:92-9. [PMID: 16761444 DOI: 10.5144/0256-4947.2006.92] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
391 Indyk D, Golub SA. The Shifting Locus of Risk-Reduction: The Critical Role of HIV Infected Individuals. Social Work in Health Care 2006;42:112-32. [DOI: 10.1300/j010v42n03_08] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
392 Ramakrishnan R, Mehta R, Sundaravaradan V, Davis T, Ahmad N. Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission. Retrovirology 2006;3:42. [PMID: 16820061 DOI: 10.1186/1742-4690-3-42] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
393 Locher AW, Didion JA. Epidemic to Endemic: The Impact of Hiv on Health Care Policy and Nursing Practice. Policy, Politics, & Nursing Practice 2003;4:62-70. [DOI: 10.1177/1527154402239457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
394 Shearer WT. POTENTIAL IMMUNE-BASED INTERVENTIONS TO REDUCE HIV-1 VERTICAL TRANSMISSION. Immunology and Allergy Clinics of North America 1998;18:421-39. [DOI: 10.1016/s0889-8561(05)70012-6] [Reference Citation Analysis]
395 Willig JH, Saag MS. HIV/AIDS: the only thing constant... J Natl Med Assoc 2009;101:1299-300. [PMID: 20070022 DOI: 10.1016/s0027-9684(15)31145-7] [Reference Citation Analysis]
396 Hampanda K, Pelowich K, Chi BH, Darbes LA, Turan JM, Mutale W, Abuogi L. A Systematic Review of Behavioral Couples-Based Interventions Targeting Prevention of Mother-to-Child Transmission in Low- and Middle-Income Countries. AIDS Behav 2021. [PMID: 34415489 DOI: 10.1007/s10461-021-03401-x] [Reference Citation Analysis]
397 Boucoiran I, Tulloch K, Pick N, Kakkar F, van Schalkwyk J, Money D, Boucher M. A case series of third-trimester raltegravir initiation: Impact on maternal HIV-1 viral load and obstetrical outcomes. Can J Infect Dis Med Microbiol 2015;26:145-50. [PMID: 26236356 DOI: 10.1155/2015/731043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
398 Hu Z, Giguel F, Hatano H, Reid P, Lu J, Kuritzkes DR. Fitness comparison of thymidine analog resistance pathways in human immunodeficiency virus type 1. J Virol 2006;80:7020-7. [PMID: 16809307 DOI: 10.1128/JVI.02747-05] [Cited by in Crossref: 47] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
399 Fajardo-Ortiz D, Lopez-Cervantes M, Duran L, Dumontier M, Lara M, Ochoa H, Castano VM. The emergence and evolution of the research fronts in HIV/AIDS research. PLoS One 2017;12:e0178293. [PMID: 28542584 DOI: 10.1371/journal.pone.0178293] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
400 Wienand A. David Goldblatt: In the Time of Aids. de arte 2017;48:7-21. [DOI: 10.1080/00043389.2013.11877178] [Reference Citation Analysis]
401 Rongkavilit C, Asmar BI. Antiretroviral drugs in pediatrics. Indian J Pediatr 2001;68:641-7. [PMID: 11519288 DOI: 10.1007/BF02752279] [Reference Citation Analysis]
402 Seu L, Mulenga LB, Siwingwa M, Sikazwe I, Lambwe N, Guffey MB, Chi BH. Characterization of HIV drug resistance mutations among patients failing first-line antiretroviral therapy from a tertiary referral center in Lusaka, Zambia. J Med Virol 2015;87:1149-57. [PMID: 25754408 DOI: 10.1002/jmv.24162] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
403 Burns F, Fenton KA, Morison L, Mercer C, Erens B, Field J, Copas AJ, Wellings K, Johnson AM. Factors associated with HIV testing among black Africans in Britain. Sex Transm Infect 2005;81:494-500. [PMID: 16326854 DOI: 10.1136/sti.2004.013755] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
404 Barry MG, Back DJ, Breckenridge AM. Zidovudine therapy in HIV infection: which patients should be treated and when. Br J Clin Pharmacol 1995;40:107-10. [PMID: 8562291 DOI: 10.1111/j.1365-2125.1995.tb05765.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
405 Berrebi A. [Virus and sterility, that which has changed. At last! How much time has been lost! J.L. Bénifla. Gynécol Obstét Fertil 2001;29:879-80]. Gynecol Obstet Fertil 2002;30:918-9; author reply 919. [PMID: 12476701 DOI: 10.1016/s1297-9589(02)00466-6] [Reference Citation Analysis]
406 Hurst SA, Appelgren KE, Kourtis AP. Prevention of mother-to-child transmission of HIV type 1: the role of neonatal and infant prophylaxis. Expert Rev Anti Infect Ther 2015;13:169-81. [PMID: 25578882 DOI: 10.1586/14787210.2015.999667] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
407 Le Campion A, Larouche A, Fauteux-Daniel S, Soudeyns H. Pathogenesis of hepatitis C during pregnancy and childhood. Viruses 2012;4:3531-50. [PMID: 23223189 DOI: 10.3390/v4123531] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
408 Celum C, Baeten JM. Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis. Antivir Ther 2012;17:1483-93. [PMID: 23221365 DOI: 10.3851/IMP2492] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
409 Paintsil E, Ghebremichael M, Romano S, Andiman WA. Absolute CD4+ T-lymphocyte count as a surrogate marker of pediatric human immunodeficiency virus disease progression. Pediatr Infect Dis J 2008;27:629-35. [PMID: 18520446 DOI: 10.1097/INF.0b013e3181693892] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
410 Moore AL, Madge S, Johnson MA. HIV and pregnancy. The Obstetrician & Gynaecologist 2002;4:197-200. [DOI: 10.1576/toag.2002.4.4.197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
411 Katz MH, Schwarcz SK, Kellogg TA, Klausner JD, Dilley JW, Gibson S, McFarland W. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health 2002;92:388-94. [PMID: 11867317 DOI: 10.2105/ajph.92.3.388] [Cited by in Crossref: 270] [Cited by in F6Publishing: 81] [Article Influence: 13.5] [Reference Citation Analysis]
412 Ciaranello AL, Perez F, Keatinge J, Park JE, Engelsmann B, Maruva M, Walensky RP, Dabis F, Chu J, Rusibamayila A, Mushavi A, Freedberg KA. What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis. PLoS Med 2012;9:e1001156. [PMID: 22253579 DOI: 10.1371/journal.pmed.1001156] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
413 Prieto LM, González-Tomé MI, Muñoz E, Fernández-Ibieta M, Soto B, Álvarez A, Navarro ML, Roa MÁ, Beceiro J, de José MI, Olabarrieta I, Lora D, Ramos JT; Madrid Cohort of HIV-Infected Mother-Infant Pairs. Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009. BMC Infect Dis 2014;14:700. [PMID: 25808698 DOI: 10.1186/s12879-014-0700-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
414 Francke S, Orosz CG, Hayes KA, Mathes LE. Effect of zidovudine on the primary cytolytic T-lymphocyte response and T-cell effector function. Antimicrob Agents Chemother 2000;44:1900-5. [PMID: 10858351 DOI: 10.1128/AAC.44.7.1900-1905.2000] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
415 Bayer R. The medicalization of HIV prevention: new opportunities beset by old challenges. Milbank Q 2014;92:434-7. [PMID: 25199892 DOI: 10.1111/1468-0009.12070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
416 Schuklenk U, Kleinsmidt A. Rethinking mandatory HIV testing during pregnancy in areas with high HIV prevalence rates: ethical and policy issues. Am J Public Health 2007;97:1179-83. [PMID: 17538051 DOI: 10.2105/AJPH.2006.093526] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
417 Bhana A, McKay MM, Mellins C, Petersen I, Bell C. Family-based HIV prevention and intervention services for youth living in poverty-affected contexts: the CHAMP model of collaborative, evidence-informed programme development. J Int AIDS Soc 2010;13 Suppl 2:S8. [PMID: 20573290 DOI: 10.1186/1758-2652-13-S2-S8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
418 de Zulueta P, Boulton M. Routine antenatal HIV testing: the responses and perceptions of pregnant women and the viability of informed consent. A qualitative study. J Med Ethics 2007;33:329-36. [PMID: 17526682 DOI: 10.1136/jme.2006.015750] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
419 Hocke C, Morlat P, Chene G, Dequae L, Dabis F. Prospective cohort study of the effect of pregnancy on the progression of human immunodeficiency virus infection. The Groupe d'Epidémiologie Clinique Du SIDA en Aquitaine. Obstet Gynecol 1995;86:886-91. [PMID: 7501333 DOI: 10.1016/0029-7844(95)00257-r] [Cited by in Crossref: 39] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
420 Weis N, Katzenstein TL, Ørbæk M, Storgaard M, Pedersen G, Johansen IS, Moseholm E. The Danish HIV Birth Cohort (DHBC) - a nationwide, prospective cohort. BMJ Open 2021;11:e044565. [PMID: 34244252 DOI: 10.1136/bmjopen-2020-044565] [Reference Citation Analysis]
421 Söderlund N, Zwi K, Kinghorn A, Gray G. Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa. BMJ 1999;318:1650-6. [PMID: 10373166 DOI: 10.1136/bmj.318.7199.1650] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 3.0] [Reference Citation Analysis]
422 Kiweewa FM, Bakaki PM, McConnell MS, Musisi M, Namirembe C, Nakayiwa F, Kusasira F, Nakintu D, Mubiru MC, Musoke P, Fowler MG. A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, "the Nevirapine Repeat Pregnancy study". BMC Public Health 2015;15:988. [PMID: 26420040 DOI: 10.1186/s12889-015-2345-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
423 Blaizot S, Maman D, Riche B, Mukui I, Kirubi B, Ecochard R, Etard JF. Potential impact of multiple interventions on HIV incidence in a hyperendemic region in Western Kenya: a modelling study. BMC Infect Dis 2016;16:189. [PMID: 27129591 DOI: 10.1186/s12879-016-1520-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
424 Duong T, Ades AE, Gibb DM, Tookey PA, Masters J. Vertical transmission rates for HIV in the British Isles: estimates based on surveillance data. BMJ 1999;319:1227-9. [PMID: 10550082 DOI: 10.1136/bmj.319.7219.1227] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 2.0] [Reference Citation Analysis]
425 Giaquinto C, Rampon O, Penazzato M, Fregonese F, De Rossi A, D'Elia R. Nucleoside and nucleotide reverse transcriptase inhibitors in children. Clin Drug Investig 2007;27:509-31. [PMID: 17638393 DOI: 10.2165/00044011-200727080-00001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
426 Heeregrave EJ, Geels MJ, Baan E, van der Sluis RM, Paxton WA, Pollakis G. Varied sensitivity to therapy of HIV-1 strains in CD4+ lymphocyte sub-populations upon ART initiation. AIDS Res Ther 2010;7:42. [PMID: 21134247 DOI: 10.1186/1742-6405-7-42] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
427 Yu J, Lai D. Interim analysis of sequential estimation‐adjusted urn models with sample size re‐estimation. Can J Statistics 2021;49:1075-92. [DOI: 10.1002/cjs.11609] [Reference Citation Analysis]
428 Dabis F, Orne-Gliemann J, Perez F, Leroy V, Newell ML, Coutsoudis A, Coovadia H; Working Group on Women and Child Health. Improving child health: the role of research. BMJ 2002;324:1444-7. [PMID: 12065272 DOI: 10.1136/bmj.324.7351.1444] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
429 Chiriboga CA. Human Immunodeficiency Virus (HIV) in Children. Curr Treat Options Neurol 2002;4:213-24. [PMID: 11931728 DOI: 10.1007/s11940-002-0038-9] [Reference Citation Analysis]
430 Mok J, Cooper S. The needs of children whose mothers have HIV infection. Arch Dis Child 1997;77:483-7. [PMID: 9496179 DOI: 10.1136/adc.77.6.483] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
431 Kuhn L, Aldrovandi G. Survival and health benefits of breastfeeding versus artificial feeding in infants of HIV-infected women: developing versus developed world. Clin Perinatol 2010;37:843-62, x. [PMID: 21078454 DOI: 10.1016/j.clp.2010.08.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
432 Gonen JS. Pregnant women deserve informed consent too. Womens Health Issues 2002;12:1-3. [PMID: 11786286 DOI: 10.1016/s1049-3867(01)00136-0] [Reference Citation Analysis]
433 Dolezal C, Frasca T, Giguere R, Ibitoye M, Cranston RD, Febo I, Mayer KH, McGowan I, Carballo-Diéguez A. Awareness of Post-Exposure Prophylaxis (PEP) and Pre-Exposure Prophylaxis (PrEP) Is Low but Interest Is High Among Men Engaging in Condomless Anal Sex With Men in Boston, Pittsburgh, and San Juan. AIDS Educ Prev 2015;27:289-97. [PMID: 26241380 DOI: 10.1521/aeap.2015.27.4.289] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 8.0] [Reference Citation Analysis]
434 Buckoreelall K, Cressey TR, King JR. Pharmacokinetic optimization of antiretroviral therapy in pregnancy. Clin Pharmacokinet 2012;51:639-59. [PMID: 23018528 DOI: 10.1007/s40262-012-0002-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
435 Marcus U. HIV infections and HIV testing during pregnancy, Germany, 1993 to 2016. Euro Surveill 2019;24. [PMID: 31796155 DOI: 10.2807/1560-7917.ES.2019.24.48.1900078] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
436 Briand N, Le Coeur S, Jourdain G, Hotrawarikarn S, Sirinontakan S, Hinjiranandana T, Kanjanavanit S, Traisathit P, McIntosh K, Lallemant M; Program for HIV Prevention and Treatment Study Group. Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in Thailand. AIDS Res Hum Retroviruses 2010;26:1163-6. [PMID: 20854205 DOI: 10.1089/aid.2010.0034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
437 Spaulding AB, Yu Q, Civitello L, Mussi-Pinhata MM, Pinto J, Gomes IM, Alarcón JO, Siberry GK, Harris DR, Hazra R. Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean. AIDS Res Hum Retroviruses 2016;32:349-56. [PMID: 26879281 DOI: 10.1089/AID.2015.0254] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
438 Fong C. Post-exposure prophylaxis for HIV infection after sexual assault: when is it indicated? Emerg Med J 2001;18:242-5. [PMID: 11435354 DOI: 10.1136/emj.18.4.242] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
439 Costa ZB, Machado GC, Avelino MM, Gomes Filho C, Macedo Filho JV, Minuzzi AL, Turchi MD, Stefani MM, de Souza WV, Martelli CM. Prevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central Brazil. BMC Infect Dis 2009;9:116. [PMID: 19635135 DOI: 10.1186/1471-2334-9-116] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
440 Günthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, Hoy JF, Mugavero MJ, Sax PE, Thompson MA, Gandhi RT, Landovitz RJ, Smith DM, Jacobsen DM, Volberding PA. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. JAMA 2016;316:191-210. [PMID: 27404187 DOI: 10.1001/jama.2016.8900] [Cited by in Crossref: 400] [Cited by in F6Publishing: 365] [Article Influence: 66.7] [Reference Citation Analysis]
441 Bardsley-Elliot A, Perry CM. Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection. Paediatr Drugs 2000;2:373-407. [PMID: 11022799 DOI: 10.2165/00128072-200002050-00005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
442 Alexander TS, Lee J, Yen-Lieberman B. Incidence of human immunodeficiency virus antibody in a prenatal population at a community hospital. Clin Diagn Lab Immunol 1999;6:140-1. [PMID: 9874679 DOI: 10.1128/CDLI.6.1.140-141.1999] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
443 Jayasuriya A, Robertson C, Allan PS. Twenty-five years of HIV management. J R Soc Med 2007;100:363-6. [PMID: 17682028 DOI: 10.1177/014107680710000811] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
444 Silverman NS, Watts DH, Hitti J, Money DM, Livingston E, Axelrod J, Ernest JM, Robbins D, DiVito MM. Initial multicenter experience with double nucleoside therapy for human immunodeficiency virus infection during pregnancy. Infect Dis Obstet Gynecol 1998;6:237-43. [PMID: 9972484 DOI: 10.1002/(SICI)1098-0997(1998)6:6<237::AID-IDOG3>3.0.CO;2-E] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
445 Escota G, Onen N. HIV-infected adolescent, young adult and pregnant smokers: important targets for effective tobacco control programs. Int J Environ Res Public Health 2013;10:2471-99. [PMID: 23778059 DOI: 10.3390/ijerph10062471] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
446 Barnes DB. “I’m Still Here”: a 10 year follow-up of women's experiences living with HIV. Care for Major Health Problems and Population Health Concerns: Impacts on Patients, Providers and Policy. Bingley: Emerald (MCB UP ); 2008. pp. 123-38. [DOI: 10.1016/s0275-4959(08)26006-0] [Cited by in Crossref: 1] [Reference Citation Analysis]
447 Palmer S, Boltz V, Martinson N, Maldarelli F, Gray G, McIntyre J, Mellors J, Morris L, Coffin J. Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission. Proc Natl Acad Sci U S A 2006;103:7094-9. [PMID: 16641095 DOI: 10.1073/pnas.0602033103] [Cited by in Crossref: 102] [Cited by in F6Publishing: 98] [Article Influence: 6.4] [Reference Citation Analysis]
448 Siberry GK. Preventing and managing HIV infection in infants, children, and adolescents in the United States. Pediatr Rev 2014;35:268-86. [PMID: 24986927 DOI: 10.1542/pir.35-7-268] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
449 Gupta A, Hughes MD, Garcia-Prats AJ, McIntire K, Hesseling AC. Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons. PLoS Med 2019;16:e1002882. [PMID: 31415563 DOI: 10.1371/journal.pmed.1002882] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
450 Sugarman J. Ethical considerations regarding oral preexposure prophylaxis in HIV prevention trials. Curr Opin HIV AIDS 2016;11:109-15. [PMID: 26633642 DOI: 10.1097/COH.0000000000000214] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
451 Mcquitty M, Mcfarland W, Kellogg TA, White E, Katz MH. Home Collection Versus Publicly Funded HIV Testing in San Francisco: Who Tests Where?: . JAIDS Journal of Acquired Immune Deficiency Syndromes 1999;21:417. [DOI: 10.1097/00126334-199908150-00010] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
452 Fitchett JR. Placental HIV transmission and vitamin D: Nutritional and immunological implications: Placental HIV transmission and vitamin D. Nutrition Bulletin 2013;38:410-3. [DOI: 10.1111/nbu.12061] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
453 Ruiz JD, Molitor F. Knowledge of treatment to reduce perinatal human immunodeficiency virus (HIV) transmission and likelihood of testing for HIV: results from two surveys of women of childbearing age. Matern Child Health J 1998;2:117-22. [PMID: 10728267 DOI: 10.1023/a:1022944907256] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
454 Kostrikis LG, Neumann AU, Thomson B, Korber BT, McHardy P, Karanicolas R, Deutsch L, Huang Y, Lew JF, McIntosh K, Pollack H, Borkowsky W, Spiegel HM, Palumbo P, Oleske J, Bardeguez A, Luzuriaga K, Sullivan J, Wolinsky SM, Koup RA, Ho DD, Moore JP. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol 1999;73:10264-71. [PMID: 10559343 DOI: 10.1128/JVI.73.12.10264-10271.1999] [Cited by in Crossref: 102] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
455 Olugbenga-Bello A, Adebimpe W, Osundina F, Abdulsalam S. Perception on prevention of mother-to-child-transmission (PMTCT) of HIV among women of reproductive age group in Osogbo, Southwestern Nigeria. Int J Womens Health 2013;5:399-405. [PMID: 23874124 DOI: 10.2147/IJWH.S45815] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
456 Crochet S, Huang CC, Fries M, Scott RK. Implementation of universal rapid human immunodeficiency virus screening on labor and delivery. Ther Adv Infect Dis 2018;5:47-54. [PMID: 29468056 DOI: 10.1177/2049936117753012] [Reference Citation Analysis]
457 Gouvêa ADN, Trajano AJB, Monteiro DLM, Rodrigues NCP, Costa JTD, Cavalcante MB, Auar DF, Gouvea EF, Taquette SR. Vertical transmission of HIV from 2007 to 2018 in a reference university hospital in Rio de Janeiro. Rev Inst Med Trop Sao Paulo 2020;62:e66. [PMID: 33027390 DOI: 10.1590/S1678-9946202062066] [Reference Citation Analysis]
458 . 8.0 Neonatal management: BHIVA guidelines for the management of HIV infection in pregnant women 2012. HIV Med 2012;13:126-33. [DOI: 10.1111/j.1468-1293.2012.1030_9.x] [Reference Citation Analysis]
459 Mannick EE, Udall JN, Kaiser M, Fuchs G, Suskind R. Nutrition and HIV infection in children. Indian J Pediatr 1996;63:615-32. [PMID: 10830030 DOI: 10.1007/BF02730805] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
460 Pagano N, Teriete P, Mattmann ME, Yang L, Snyder BA, Cai Z, Heil ML, Cosford NDP. An integrated chemical biology approach reveals the mechanism of action of HIV replication inhibitors. Bioorg Med Chem 2017;25:6248-65. [PMID: 28442262 DOI: 10.1016/j.bmc.2017.03.061] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
461 Wilson TE, Minkoff H. Mandatory HIV testing of infants and rates of follow-up care. Am J Public Health 1999;89:1583. [PMID: 10511847 DOI: 10.2105/ajph.89.10.1583] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
462 Mandelbrot L. [Human immunodeficiency virus: current pregnancy aspects]. Arch Pediatr 2000;7 Suppl 2:295s-8s. [PMID: 10904750 DOI: 10.1016/s0929-693x(00)80077-9] [Reference Citation Analysis]
463 Golub SA, Kowalczyk W, Weinberger CL, Parsons JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr 2010;54:548-55. [PMID: 20512046 DOI: 10.1097/QAI.0b013e3181e19a54] [Cited by in Crossref: 192] [Cited by in F6Publishing: 133] [Article Influence: 16.0] [Reference Citation Analysis]
464 Firth J, Jeyaseelan L, Christina S, Vonbara V, Jeyaseelan V, Elan S, Abraham S, Joseph I, David S, Cu-Uvin S, Lurie M, Wanke C, Lionel J. HIV-1 seroprevalence and awareness of mother-to-child transmission issues among women seeking antenatal care in Tamil Nadu, India. J Int Assoc Physicians AIDS Care (Chic) 2010;9:206-13. [PMID: 20530464 DOI: 10.1177/1545109710371132] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
465 Fernández MI, Wilson TE, Ethier KA, Walter EB, Gay CL, Moore J. Acceptance of HIV testing during prenatal care. Perinatal Guidelines Evaluation Project. Public Health Rep 2000;115:460-8. [PMID: 11236018 DOI: 10.1093/phr/115.5.460] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 1.9] [Reference Citation Analysis]
466 Sklar PA, Bathgate SL, Young HA, Parenti DM. Care of HIV-infected pregnant women in maternal-fetal medicine programs. Infect Dis Obstet Gynecol 2001;9:81-7. [PMID: 11495558 DOI: 10.1155/S1064744901000151] [Reference Citation Analysis]
467 Finn L. It's for (y)our own good: an analysis of the discourses surrounding mandatory, unblinded HIV testing of newborns. J Med Humanit 1998;19:133-62. [PMID: 11657069 DOI: 10.1023/a:1025027230068] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
468 Ayouba A, Cannou C, Nugeyre MT, Barré-Sinoussi F, Menu E. Distinct efficacy of HIV-1 entry inhibitors to prevent cell-to-cell transfer of R5 and X4 viruses across a human placental trophoblast barrier in a reconstitution model in vitro. Retrovirology 2008;5:31. [PMID: 18377645 DOI: 10.1186/1742-4690-5-31] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
469 Raboud J, Li M, Blitz S, D'Aquila A, Sterling S, Walmsley S. Factors associated with HIV-positive women carrying pregnancies to term. J Obstet Gynaecol Can 2010;32:756-62. [PMID: 21050507 DOI: 10.1016/s1701-2163(16)34616-3] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
470 Marsit CJ, Brummel SS, Kacanek D, Seage GR 3rd, Spector SA, Armstrong DA, Lester BM, Rich K; Pediatric HIV/AIDS Cohort Studies Network. Infant peripheral blood repetitive element hypomethylation associated with antiretroviral therapy in utero. Epigenetics 2015;10:708-16. [PMID: 26067216 DOI: 10.1080/15592294.2015.1060389] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
471 Shapiro MB, Cheever T, Malherbe DC, Pandey S, Reed J, Yang ES, Wang K, Pegu A, Chen X, Siess D, Burke D, Henderson H, Lewinsohn R, Fischer M, Stanton JJ, Axthelm MK, Kahl C, Park B, Lewis AD, Sacha JB, Mascola JR, Hessell AJ, Haigwood NL. Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity. Nat Commun 2020;11:70. [PMID: 31911610 DOI: 10.1038/s41467-019-13972-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
472 Côté SJ, Halperin SA. Compliance with recommendations for routine HIV screening during pregnancy in Halifax. Paediatr Child Health 2002;7:81-4. [PMID: 20046277 DOI: 10.1093/pch/7.2.81] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
473 Arnold S, Degani N, King S. Lack of adverse events associated with pre- and postnatal antiretroviral therapy exposure: a retrospective review of 43 children followed up at 4-7 years of age. AIDS Patient Care STDS 2003;17:53-5. [PMID: 12650143 DOI: 10.1089/108729103321150773] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
474 Illán Ramos M, Soto Sánchez B, Mazariegos Orellana D, Prieto Tato LM, Guillén Martín S, Navarro Gómez ML, Del Rosal Rabes T, Escosa García L, Roa Francia MÁ, Beceiro Mosquera J, Olabarrieta Arnal I, Muñoz Gálligo E, Viñuela Beneitez MC, Regidor Sáez FJ, Serrano García I, Berzosa Sánchez A, Callejas Caballero I, Ramos Amador JT; Madrid Cohort of HIV-infected Mother-infant pairs. Safety and Experience With Combined Antiretroviral Prophylaxis in Newborn at High-risk of Perinatal HIV Infection, in a Cohort of Mother Living With HIV-infant Pairs. Pediatr Infect Dis J 2021;40:1096-100. [PMID: 34870390 DOI: 10.1097/INF.0000000000003297] [Reference Citation Analysis]
475 Nielsen-Saines K, Mitchell K, Kerin T, Fournier J, Kozina L, Andrews B, Cortado R, Bolan R, Flynn R, Rotheram MJ, Abdalian SE, Bryson Y; Adolescent Medicine Trials Network (ATN) CARES Team., Mobilizing Minds Research Group. Acute HIV Infection in Youth: Protocol for the Adolescent Trials Network 147 (ATN147) Comprehensive Adolescent Research and Engagement Studies (CARES) Study. JMIR Res Protoc 2019;8:e10807. [PMID: 30650057 DOI: 10.2196/10807] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
476 Ciaranello AL, Perez F, Maruva M, Chu J, Engelsmann B, Keatinge J, Walensky RP, Mushavi A, Mugwagwa R, Dabis F, Freedberg KA; CEPAC-International Investigators. WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers. PLoS One 2011;6:e20224. [PMID: 21655097 DOI: 10.1371/journal.pone.0020224] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
477 Acosta EP, Page LM, Fletcher CV. Clinical pharmacokinetics of zidovudine. An update. Clin Pharmacokinet 1996;30:251-62. [PMID: 8983858 DOI: 10.2165/00003088-199630040-00001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 1.9] [Reference Citation Analysis]
478 Abrams EJ, Ananworanich J, Archary M, Ngongondo M, Brouwers P. Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration. J Acquir Immune Defic Syndr 2018;78 Suppl 1:S32-9. [PMID: 29994918 DOI: 10.1097/QAI.0000000000001747] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
479 Ammann A. Inequalities in clinical research. Lancet 2016;388:2868-9. [PMID: 27979401 DOI: 10.1016/S0140-6736(16)32396-0] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
480 John GC, Kreiss J. Mother-to-child transmission of human immunodeficiency virus type 1. Epidemiol Rev 1996;18:149-57. [PMID: 9021309 DOI: 10.1093/oxfordjournals.epirev.a017922] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 2.6] [Reference Citation Analysis]
481 Kell P, Desmond N. Antenatal attenders and HIV testing. Int J STD AIDS 1995;6:299; author reply 300. [PMID: 7548298 DOI: 10.1177/095646249500600421] [Reference Citation Analysis]
482 Chung MH, McKenzie KP, Richardson BA, John-Stewart GC, Coombs RW, De Vuyst H, Njoroge JW, Nyongesa-Malava E, Sakr SR, Mugo NR. Cervical HIV-1 RNA shedding after cryotherapy among HIV-positive women with cervical intraepithelial neoplasia stage 2 or 3. AIDS 2011;25:1915-9. [PMID: 21716072 DOI: 10.1097/QAD.0b013e32834a3654] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
483 Jia Y, Sun J, Fan L, Song D, Tian S, Yang Y, Jia M, Lu L, Sun X, Zhang S, Kulczycki A, Vermund SH. Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province. Int J Epidemiol 2008;37:1287-96. [PMID: 18922804 DOI: 10.1093/ije/dyn196] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
484 Buchholz B, Hien S, Baumann U; für die Pädiatrische Arbeitsgruppe AIDS (PAAD). Verhinderung der vertikalen HIV1-Transmission: Ein Beispiel gelungener Präventivmedizin. Monatsschr Kinderheilkd 2012;160:1211-5. [DOI: 10.1007/s00112-012-2817-z] [Reference Citation Analysis]
485 Lin SH, Wang Y, Hartley SW, Karyadi DM, Lee OW, Zhu B, Zhou W, Brown DW, Beilstein-Wedel E, Hazra R, Kacanek D, Chadwick EG, Marsit CJ, Poirier MC, Brummel SS, Chanock SJ, Engels EA, Machiela MJ; Pediatric HIV/AIDS Cohort Study. In-utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns. AIDS 2021;35:1525-35. [PMID: 33756513 DOI: 10.1097/QAD.0000000000002894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
486 Lipshultz SE, Williams PL, Zeldow B, Wilkinson JD, Rich KC, van Dyke RB, Seage GR 3rd, Dooley LB, Kaltman JR, Siberry GK, Mofenson LM, Shearer WT, Colan SD; Pediatric HIVAIDS Cohort Study (PHACS). Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers. AIDS 2015;29:91-100. [PMID: 25562493 DOI: 10.1097/QAD.0000000000000499] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
487 Bayer R. The debate over maternal-fetal HIV transmission prevention trials in Africa, Asia, and the Caribbean: racist exploitation or exploitation of racism? Am J Public Health 1998;88:567-70. [PMID: 9550995 DOI: 10.2105/ajph.88.4.567] [Cited by in Crossref: 47] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
488 Funk MJ, Belinson SE, Pimenta JM, Morsheimer M, Gibbons DC. Mitochondrial disorders among infants exposed to HIV and antiretroviral therapy. Drug Saf 2007;30:845-59. [PMID: 17867723 DOI: 10.2165/00002018-200730100-00004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
489 Maimaiti R, Andersson R. Awareness and attitudes about HIV among pregnant women in Aksu, northwest China. Open AIDS J 2008;2:72-7. [PMID: 19274068 DOI: 10.2174/1874613600802010072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
490 Stanton B. Good news for everyone? Am J Public Health 1997;87:1917-9. [PMID: 9431274 DOI: 10.2105/ajph.87.12.1917] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
491 Okafor I, Ugwu E, Obi S, Odugu B. Virtual Elimination of Mother-to-Child Transmission of Human Immunodeficiency Virus in Mothers on Highly Active Antiretroviral Therapy in Enugu, South-Eastern Nigeria. Ann Med Health Sci Res 2014;4:615-8. [PMID: 25221715 DOI: 10.4103/2141-9248.139344] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
492 Sivarajah V, Venus K, Yudin MH, Murphy KE, Morrison SA, Tan DH. Does maternal HSV-2 coinfection increase mother-to-child transmission of HIV? A systematic review. Sex Transm Infect 2017;93:535-42. [PMID: 28600331 DOI: 10.1136/sextrans-2016-052921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
493 Al Aqeel AI. Prevention and Care of Genetic Disorders: An Islamic Perspective. In: Teebi AS, editor. Genetic Disorders Among Arab Populations. Berlin: Springer Berlin Heidelberg; 2010. pp. 705-23. [DOI: 10.1007/978-3-642-05080-0_24] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
494 Scott RK, Crochet S, Huang CC. Universal Rapid Human Immunodeficiency Virus Screening at Delivery: A Cost-Effectiveness Analysis. Infect Dis Obstet Gynecol 2018;2018:6024698. [PMID: 29731602 DOI: 10.1155/2018/6024698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
495 Loutfy MR, Walmsley SL. Treatment of HIV infection in pregnant women: antiretroviral management options. Drugs 2004;64:471-88. [PMID: 14977385 DOI: 10.2165/00003495-200464050-00002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
496 Pearson DA, Doyle MD, Pickering LK, Ortegon J. Pediatric HIV infection: A review of epidemiology, clinical manifestations, and current intervention. J Dev Phys Disabil 1996;8:179-210. [DOI: 10.1007/bf02578389] [Reference Citation Analysis]
497 Kim SK, Choi JA, Kim MH, Kim MS, Lee KC. Gender Reassignment Surgery in Human Immunodeficiency Virus-Positive Patients: A Report of Two Cases. Arch Plast Surg 2015;42:776-82. [PMID: 26618127 DOI: 10.5999/aps.2015.42.6.776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
498 Hillyer JF. George V. Hillyer (1943-2015). Journal of Parasitology 2016;102:659-61. [DOI: 10.1645/16-110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
499 Ortigão MB. Aids em crianças: considerações sobre a transmissão vertical. Cad Saúde Pública 1995;11:142-8. [DOI: 10.1590/s0102-311x1995000100021] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
500 Alagaratnam J, Peters H, Francis K, Kay N, Gilleece Y, Finnerty FP, Grimes RE, Parry S, Portman M, Wait BC, Shah R, Roedling S, Hawkins DA, Chitty S, Sarner L, Marcus R, Hartley A, Nori AV, Rosenvinge M, Taylor GP; London HIV Perinatal Research Group. An observational study of initial HIV RNA decay following initiation of combination antiretroviral treatment during pregnancy. AIDS Res Ther 2020;17:41. [PMID: 32660502 DOI: 10.1186/s12981-020-00297-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
501 Rousseau CM, Nduati RW, Richardson BA, Steele MS, John-Stewart GC, Mbori-Ngacha DA, Kreiss JK, Overbaugh J. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis 2003;187:741-7. [PMID: 12599047 DOI: 10.1086/374273] [Cited by in Crossref: 147] [Cited by in F6Publishing: 136] [Article Influence: 7.7] [Reference Citation Analysis]
502 Demir M, Laywell ED. Neurotoxic effects of AZT on developing and adult neurogenesis. Front Neurosci 2015;9:93. [PMID: 25852464 DOI: 10.3389/fnins.2015.00093] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
503 Schramm DB, Kuhn L, Gray GE, Tiemessen CT. In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers. J Acquir Immune Defic Syndr 2006;42:545-53. [PMID: 16837862 DOI: 10.1097/01.qai.0000225009.30698.ce] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
504 Hompe ED, Mangold JF, Kumar A, Eudailey JA, McGuire E, Haynes BF, Moody MA, Wright PF, Fouda GG, Giorgi EE, Gao F, Permar SR. Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine Trials. mSphere 2020;5:e00254-20. [PMID: 32493720 DOI: 10.1128/mSphere.00254-20] [Reference Citation Analysis]
505 Mukherjee K. Cost-effectiveness of Childbirth Strategies for Prevention of Mother-to-child Transmission of HIV Among Mothers Receiving Nevirapine in India. Indian J Community Med 2010;35:29-33. [PMID: 20606916 DOI: 10.4103/0970-0218.62550] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
506 Downing M, Youden L, Halperin BA, Scott H, Smith B, Halperin SA. Prenatal Screening for HIV in Nova Scotia: Survey of Postpartum Women and Audit of Current Prenatal Screening Practices. Can J Infect Dis Med Microbiol 2006;17:224-8. [PMID: 18382632 DOI: 10.1155/2006/195842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
507 Kelley CE, Paul SM, Vali FM, Caruso JM, Martin RM, Fleming PL. Toward elimination of perinatal HIV transmission: New Jersey hospital barriers to rapid HIV testing in labor and delivery, 2005. Public Health Rep 2011;126:145-52. [PMID: 21337941 DOI: 10.1177/003335491112600121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
508 Musoke P, Namukwaya Z, Mosha LB. Prevention and Treatment of Pediatric HIV Infection. Curr Trop Med Rep 2018;5:24-30. [DOI: 10.1007/s40475-018-0137-7] [Reference Citation Analysis]
509 Barbosa RM, Cabral CD, do Lago TD, Pinho AA. Differences in the Access to Sterilization between Women Living and Not Living with HIV: Results from the GENIH Study, Brazil. PLoS One 2016;11:e0164887. [PMID: 27812146 DOI: 10.1371/journal.pone.0164887] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
510 İnkaya AÇ, Örgül G, Halis N, Alp Ş, Kara A, Özyüncü Ö, Yurdakok M, Ünal S, Beksaç MS. Perinatal outcomes of twenty-five human immunodeficiency virus-infected pregnant women: Hacettepe University experience. J Turk Ger Gynecol Assoc 2020;21:180-6. [PMID: 31564083 DOI: 10.4274/jtgga.galenos.2019.2019.0033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
511 Auerbach JD, Coates TJ. HIV prevention research: accomplishments and challenges for the third decade of AIDS. Am J Public Health 2000;90:1029-32. [PMID: 10897177 DOI: 10.2105/ajph.90.7.1029] [Cited by in Crossref: 65] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
512 Kelesidis T, Landovitz RJ. Preexposure prophylaxis for HIV prevention. Curr HIV/AIDS Rep 2011;8:94-103. [PMID: 21465112 DOI: 10.1007/s11904-011-0078-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
513 King CC, Ellington SR, Kourtis AP. The role of co-infections in mother-to-child transmission of HIV. Curr HIV Res 2013;11:10-23. [PMID: 23305198 DOI: 10.2174/1570162x11311010003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 16] [Article Influence: 0.2] [Reference Citation Analysis]
514 Burton R, Giddy J, Stinson K. Prevention of mother-to-child transmission in South Africa: an ever-changing landscape. Obstet Med 2015;8:5-12. [PMID: 27512452 DOI: 10.1177/1753495X15570994] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
515 Chougrani I, Luton D, Matheron S, Mandelbrot L, Azria E. Safety of protease inhibitors in HIV-infected pregnant women. HIV AIDS (Auckl) 2013;5:253-62. [PMID: 24101883 DOI: 10.2147/HIV.S33058] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
516 Bennett R. Routine antenatal HIV testing and informed consent: an unworkable marriage? J Med Ethics 2007;33:446-8. [PMID: 17664300 DOI: 10.1136/jme.2006.018861] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
517 Petrou S. Current controversies in the treatment of HIV infection and AIDS. An economic perspective. Pharmacoeconomics 1996;10:105-8. [PMID: 10163412 DOI: 10.2165/00019053-199610020-00001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
518 Romeu GA, Paiva LVD, Fé MMM. Pharmaceutical care to pregnant women carrying human immunodeficiency virus. Braz J Pharm Sci 2009;45:593-602. [DOI: 10.1590/s1984-82502009000300026] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
519 Knapp KM. Prevention of Mother-to-Child Human Immunodeficiency Virus Transmission in Resource-Limited Countries. Pediatr Clin North Am 2022;69:1-18. [PMID: 34794668 DOI: 10.1016/j.pcl.2021.08.007] [Reference Citation Analysis]
520 O'Connor KS, MacDonald SE, Hartling L, Seguin RM, Hollands H, Mowat DL, Hoey JR, Massé R, Rekart ML. The influence of prevalence and policy on the likelihood that a physician will offer HIV screening in pregnancy. Can J Public Health 2002;93:31-5. [PMID: 11925697 [PMID: 11925697 DOI: 10.1007/bf03404414] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
521 Jain A, Davis MM. Recent advances: Paediatrics. BMJ 2001;322:1469-72. [PMID: 11408306 DOI: 10.1136/bmj.322.7300.1469] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
522 . The pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus (P2C2 HIV) infection study: design and methods. The P2C2 HIV Study Group. J Clin Epidemiol 1996;49:1285-94. [PMID: 8892497 DOI: 10.1016/s0895-4356(96)00230-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
523 Steiner RJ, Finocchario-Kessler S, Dariotis JK. Engaging HIV care providers in conversations with their reproductive-age patients about fertility desires and intentions: a historical review of the HIV epidemic in the United States. Am J Public Health 2013;103:1357-66. [PMID: 23763424 DOI: 10.2105/AJPH.2013.301265] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
524 Sperling R. Zidovudine. Infect Dis Obstet Gynecol 1998;6:197-203. [PMID: 9894173 DOI: 10.1002/(SICI)1098-0997(1998)6:5<197::AID-IDOG2>3.0.CO;2-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.0] [Reference Citation Analysis]
525 Williams PL, Marino M, Malee K, Brogly S, Hughes MD, Mofenson LM; PACTG 219C Team. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants. Pediatrics 2010;125:e250-60. [PMID: 20083530 DOI: 10.1542/peds.2009-1112] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
526 Moussa M, Roques P, Fievet N, Menu E, Maldonado-Estrada JG, Brunerie J, Frydman R, Fritel X, Herve F, Chaouat G. Placental cytokine and chemokine production in HIV-1-infected women: trophoblast cells show a different pattern compared to cells from HIV-negative women. Clin Exp Immunol 2001;125:455-64. [PMID: 11531954 DOI: 10.1046/j.1365-2249.2001.01629.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
527 Daou S, Calmy A. [HIV prevention using pre-exposure prophylaxis]. Rev Med Interne 2011;32:658-62. [PMID: 21945111 DOI: 10.1016/j.revmed.2011.08.007] [Reference Citation Analysis]
528 Briand N, Lallemant M, Jourdain G, Techapalokul S, Tunthanathip P, Suphanich S, Chanpoo T, Traisathit P, McIntosh K, Le Coeur S. Haematological safety of perinatal zidovudine in pregnant HIV-1-infected women in Thailand: secondary analysis of a randomized trial. PLoS Clin Trials 2007;2:e11. [PMID: 17476315 DOI: 10.1371/journal.pctr.0020011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]